Molecular epidemiology of antibiotic-resistant enterococcus spp. from farm to food-production chain in intensive poultry production in KwaZulu-Natal, South Africa. by Molechan, Chantal.
 
 
MOLECULAR EPIDEMIOLOGY OF ANTIBIOTIC-RESISTANT 
ENTEROCOCCUS SPP.  FROM FARM TO FOOD-PRODUCTION CHAIN IN 






A dissertation submitted in fulfilment of the requirements for the degree of Master of Medical 
Science (Medical Microbiology) in the School of Laboratory Medicine and Medical Sciences, 
University of KwaZulu-Natal. 
Supervisor 
Professor Sabiha Yusuf Essack 
Co-supervisors 
Dr. Linda Bester 




MOLECULAR EPIDEMIOLOGY OF ANTIBIOTIC-RESISTANT 
ENTEROCOCCUS SPP. FROM FARM TO FOOD-PRODUCTION CHAIN IN 







A dissertation submitted to the School of Laboratory Medicine and Medical Sciences, College 
of Health Science, University of KwaZulu-Natal, Westville Campus, for the degree of Master of 
Medical Science (Medical Microbiology). 
 
This is a dissertation by manuscript with an overall introduction and final summary. 
 
This is to certify that the content of this dissertation is the original research work of Miss 
Chantal Molechan, supervised by; 
 
Supervisor: Signed: -------------------------- Name: Prof Sabiha Y. Essack Date: ---------------- 
 
Co-supervisor Signed: -------------------------- Name: Dr Linda Bester  Date: ---------------- 
 







I, Miss Chantal Molechan, declare as follows:  
 
1. That the work described in this dissertation has not been submitted to UKZN or 
any other tertiary institution for purposes of obtaining an academic qualification, 
whether by myself or any other party.  
 
2. That my contribution to the project was as follows:  
• The research reported in this dissertation, except where otherwise indicated, 
is my original work  
• This dissertation does not contain other person’s data, pictures, graphs or other 
information unless specifically acknowledged as being sourced from other 
persons.  
 
3. This dissertation does not contain other person’s writing unless specifically 
acknowledged as being sourced from other researchers. Where other written 
sources have been quoted, then:  
• Their words have been re-written, but the general information attributed to 
them has been referenced.  
• Where their exact words have been used, then their writing has been placed in 


















I would like to express my sincere gratitude to the following people for their role in this 
research: 
• Professor Sabiha Yusuf Essack, for her enthusiastic guidance and immense 
intellectual leadership throughout the study. 
• Dr. Linda Bester, for her patience, guidance and willingness to teach. 
• Mr. Daniel Gyamfi Amoako, for his highly appreciated mentorship. Thank you 
for always expressing confidence in my abilities, all the while encouraging and 
assisting my growth as a scientist. 
• Dr. Akebe Luther King Abia for his kind support and assistance during difficulties 
in the study. Thank you for allowing me opportunities to learn and grow. 
• Biomedical Resource Unit (BRU) colleagues and friends especially Estelle 
Ramchuran, Nongcebo Malinga and Anou Somboro for all the motivation and 
support.  
• My family, for their patience and support throughout all my academic endeavours. 
• Lastly, my best friend and pillar of strength, Letitia Moodley. Thank you for 
sharing in this journey every step of the way.  
• I would like to acknowledge the financial support from the National Research 
Foundation.  
Any omissions and shortcomings that may be identified in this work remain the sole 










TABLE OF CONTENTS 
DECLARATION ............................................................................................................ ii 
ACKNOWLEDGEMENTS .......................................................................................... iii 
LIST OF FIGURES ....................................................................................................... vi 
LIST OF TABLES ........................................................................................................ vii 
LIST OF ABBREVIATIONS AND ACRONYMS ................................................... viii 
APPENDICES ................................................................................................................. x 
ABSTRACT ................................................................................................................... xi 
CHAPTER 1 .................................................................................................................. 13 
INTRODUCTION AND LITERATURE REVIEW ................................................. 13 
1.1 Introduction ........................................................................................................... 13 
1.2 Literature review ................................................................................................... 13 
1.2.1 Antibiotic resistance ....................................................................................... 13 
1.2.2 Use of antibiotics in food animals .................................................................. 15 
1.2.3 Consumption of antibiotics in intensive food-animal production .................. 16 
1.2.4 One health approach ....................................................................................... 19 
1.2.5 Intrinsic and acquired Resistance ................................................................... 20 
1.2.6 Enterococcus spp.: commensals and pathogens ............................................. 21 
1.2.7 Agricultural contribution to the rise of antibiotic-resistance in Enterococcus 
spp. .......................................................................................................................... 22 
1.2.8 Mechanisms of antibiotic resistance in Enterococcus spp.. ........................... 25 
1.2.8.1 Resistance against cell wall inhibitors ........................................................ 25 
1.2.8.2 Resistance against antibiotics that hinder protein synthesis........................ 30 
1.2.8.3 Inhibition of folic acid metabolism ............................................................. 35 
1.2.9 Virulence factors and pathogenesis of Enterococcus spp.. ............................ 36 
1.2.10 Mobile genetic elements............................................................................... 40 
1.2.11 Role of plasmids in the dissemination of antibiotic resistance .................... 43 
1.2.12 CRISPR-Cas and its role in the acquisition of mobile genetic elements ..... 47 
1.2.13 Prevalence of antibiotic-resistant enterococci in food animals and the 
implications for human health ................................................................................. 48 
1.2.14 Prevalence of antibiotic-resistant enterococci in South Africa .................... 49 
1.2.15 Justification for study ................................................................................... 50 
1.3 Aim ....................................................................................................................... 50 
1.4 Objectives ............................................................................................................. 50 
v 
 
1.5 Study outline ......................................................................................................... 51 
1.6 Summary of methodology .................................................................................... 51 
References ................................................................................................................... 53 
CHAPTER TWO .......................................................................................................... 83 
Molecular epidemiology of antibiotic-resistant Enterococcus spp.  from farm to food-
production chain in intensive poultry production in KwaZulu-Natal, South Africa .. 84 
CHAPTER 3 ................................................................................................................ 122 
3.1 Conclusions ......................................................................................................... 122 
3.2 Limitations .......................................................................................................... 123 
3.3 Future recommendations ..................................................................................... 124 
APPENDICES ............................................................................................................. 125 
Appendix 1: Biomedical Research Ethics Committee (BREC) approval letter ....... 125 
Appendix 2: Animal Research Ethics Committee (AREC) approval letter .............. 126 
Appendix 3: Department of Agriculture, Forestry and Fisheries (DAFF) record  ... 127 
Appendix 4:  Agarose gel electrophoresis banding patterns showing the molecular 
confirmation of the Enterococcus genus and species ............................................... 128 
Appendix 5: Agarose gel electrophoresis banding patterns of real-time PCR 
amplification of antibiotic resistance genes .............................................................. 129 
Appendix 6: Agarose gel electrophoresis banding patterns of real-time PCR 
amplification of virulence genes ............................................................................... 130 
Appendix 7: Table of raw data ................................................................................. 131 
Appendix 8: Farm personnel consent forms ............................................................. 139 
Appendix 9: Repetitive element palindromic-PCR agarose gel electrophoresis images












LIST OF FIGURES 
Chapter 2 
Figure 1: Distribution of Enterococcus spp. along the farm to food-production chain 
continuum. 
Figure 2: Prevalence of all Enterococcus spp. showing resistant profiles along the farm 
to food-production chain continuum. 
Figure 3: Prevalence of all Enterococcus spp. isolates showing intermediate 
susceptibility along the farm to food-production chain continuum.  
Figure 4: Dendrogram showing REP-type groups of E. faecalis isolates, based on the 
similarity index, recovered along the farm to food-production chain continuum. 
Figure 5: Dendrogram showing REP-type groups of E. faecium isolates, based on the 
















LIST OF TABLES 
Chapter 2 
Table 1: List of genus- and species-specific primers and control strains used in the study. 
Table 2: List of antibiotic resistance genes primers.  
Table 3: List of virulence genes primers. 
Table 4: Susceptibility profile of all isolates recovered from the farm to food-production 
chain continuum. 
Table 5: Multidrug-resistant profiles of Enterococcus isolates. 
Table 6: Prevalence of ABR genes in Enterococcus spp. 

















LIST OF ABBREVIATIONS AND ACRONYMS 
ABR   Antibiotic resistance 
AGPs   Antibiotic growth promoters 
AMEs   Aminoglycoside-modifying enzymes 
AMR   Antimicrobial resistance 
API   Analytical profile index 
AS   Aggregation substance 
AST   Antimicrobial susceptibility testing 
BRICS  Brazil, Russia, India, China and South Africa 
CC   Clonal complex 
CLSI   Clinical and Laboratory Standards Institute 
CRISPR  Clustered Regularly Interspaced Palindromic Repeats 
Cu   Copper 
EU   European Union 
FAO   Food and Agricultural Organization of the United Nations 
FDA   Food and Drug Administration 
GAP   Global Action Plan 
GIT   Gastro-intestinal tract 
HLGR  High-level gentamicin resistant 
IS   Insertion sequences 
LSAP   Lincosamides, Streptogramin A and Pleuromutilins 
MDR   Multidrug-resistant 
MLS   Macrolides, Lincosamides and Streptogramins 
ix 
 
MLSB   Macrolides, Lincosamides and Streptogramin B 
MLST   Multilocus sequence typing 
MRSA  Methicillin-resistant Staphylococcus aureus  
MSCRAMMs Microbial surface components recognizing adhesive matrix 
molecules 
NTC No template control 
PBPs   Penicillin-binding proteins 
PCR   Polymerase chain reaction 
PFGE   Pulse-field gel electrophoresis 
QD   Quinupristin-dalfopristin 
REP-PCR  Repetitive element palindromic-PCR 
VREfm  Vancomycin-resistant E. faecium 
VRE   Vancomycin-resistant enterococci 
WHO   World Health Organization 











Appendix 1 Biomedical Research Ethics Committee (BREC) Approval 
Appendix 2 Animal Research Ethics Committee (AREC) Approval 
Appendix 3 Department of Agriculture, Forestry and Fisheries (DAFF) Record 
Appendix 4  Agarose gel electrophoresis banding patterns showing the molecular 
confirmation of the Enterococcus genus and species 
Appendix 5  Agarose gel electrophoresis banding patterns of real-time PCR 
amplification of antibiotic resistance genes 
Appendix 6  Agarose gel electrophoresis banding patterns of real-time PCR 
amplification of virulence genes 
Appendix 7  Table of raw data 
Appendix 8  Farm personnel consent forms 
Appendix 9: Repetitive element palindromic-PCR agarose gel electrophoresis images 
 
SUPPLEMENTARY MATERIAL  











Extensive antibiotic use in intensively-farmed poultry exerts selection pressure for the 
emergence of multidrug-resistant pathogens. The aim of this study was to determine the 
antibiotic resistance and virulence profiles of Enterococcus spp. along the farm to food-
production chain continuum in an intensive poultry system in the uMgungundlovu 
District in Kwazulu-Natal, South Africa.  
A total of 187 samples along the poultry farm to food-production chain continuum (litter, 
faeces, transport, holding, abattoir and retail meat) were evaluated for the presence of 
Enterococcus spp. Molecular confirmation by PCR, targetting the genus- (tuf) and 
species-specific (sodA) genes was undertaken. Susceptibility profiles were assessed by 
Kirby-Bauer disk diffusion against the WHO-AGISAR recommended panel of antibiotics 
for Enterococcus spp. using CLSI guidelines. Antibiotic resistance and virulence genes 
were detected using real-time PCR. Genetic relatedness between isolates across the 
continuum was evaluated by REP-PCR.  
Of 134 isolates identified across the continuum, with a prevalence of 72%, molecular 
speciation confirmed the isolates as E. faecalis (36%), E. faecium (31%), E. gallinarum 
(2%) and other Enterococcus spp. (31%). Resistance to tetracycline (80%), erythromycin 
(71%), nitrofurantoin (17%), ampicillin (15%), streptomycin (15%), chloramphenicol 
(11%), ciprofloxacin (5%), tigecycline (4%), gentamicin (4%), teicoplanin (3%) was 
observed among Enterococcus spp. but no vancomycin resistance (0%). E. faecium 
displayed 24% resistance, and 21% were of intermediate susceptibility to quinupristin-
dalfopristin. Twenty-one percent (21%) of E. faecalis and 100% of E. gallinarum, also 
showed intermediate susceptibility to vancomycin. Forty-three percent (43%) of E. 
faecium were multidrug-resistant (MDR) (resistant to 1 or more antibiotics in 3 or more 
antibiotic classes). The most frequently observed antibiotic resistance genes, associated 
with the phenotypic profiles, were tetM (76%) and ermB (67%) with a smaller percentage 
noted for aph(3’)-IIIa (12%) and vanC1 (1%). Virulence genes efaAFs (100%), cpd 
(96%) and gelE (81%) were more frequently detected in E. faecalis. The cell wall adhesin 
(efaAFm) was more common in E. faecium (100%) and other Enterococcus spp. (71%). 
Clonality evaluated by REP-PCR revealed that isolates along the continuum are highly 
xii 
 
diverse with major REP-types often consisting of isolates from the same sampling point 
in the continuum.  
This study highlights MDR Enterococcus in the poultry food production chain with 
isolates harbouring both resistance and virulence genes. This can serve as a reservoir for 
the potential transfer of these genes from poultry to humans through the farm to food-
production chain continuum. The findings underscore the need for routine antibiotic 





Molecular epidemiology of antibiotic-resistant Enterococcus spp.  from farm to food-
production chain in intensive poultry production in KwaZulu-Natal, South Africa 
CHAPTER 1  
INTRODUCTION AND LITERATURE REVIEW 
1.1 Introduction 
The misuse of antibiotics in intensive animal farming is a major driving force for the 
emergence of antibiotic-resistant bacteria globally. It is estimated that the global annual 
consumption of antibiotics in farmed chickens is approximately 148 mg antibiotic per kg 
of animal produced (Van Boeckel et al., 2015). The selective pressure exerted by 
antibiotics can engender multidrug resistance, including by co-selection (Tello et al., 
2012). This is a major concern since multidrug-resistant (MDR) pathogens have emerged 
that are resistant to last resort antibiotics, leaving limited options for treatment (Cai et al., 
2012; Venter et al., 2017b). Enterococcus spp., commonly found in nature and microbiota 
of humans and animals, have emerged as one of the most notorious global nosocomial 
pathogens (Guzman Prieto et al., 2016). Vancomycin was among the preferred treatments 
for resistant enterococcal infections. However, the emergence of vancomycin-resistant 
enterococci (VRE) has been observed globally. The high prevalence of MDR VRE has 
implications for human health as vancomycin is among the antibiotics of last resort for 
the treatment of infection caused by Gram-positive bacteria (Schmidt, 2011). There is 
currently limited data in South Africa based on the molecular epidemiology of 
enterococci in poultry. Furthermore, no studies have been conducted to investigate this 
along the farm to food-production continuum. There is, therefore a need to delineate the 
burden of antibiotic-resistant Enterococcus spp. in poultry to inform evidence-based 
measures for its containment. 
 
1.2 Literature review 
1.2.1 Antibiotic resistance 
In 1928, Sir Alexander Fleming stumbled upon a fungal metabolite called penicillin 
(Fleming, 1929). Within 12 years of its discovery, Fleming and Howard Florey devised 
a method to harvest this substance that marked the dawn of the golden age of antibiotics. 
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An antibiotic can be defined as a natural or synthetic compound that can inhibit the 
growth and proliferation of bacteria (WHO, 2015). Due to this desirable property, the use 
of antibiotics proved to be a powerful tool with which infections could be overcome.  
 
Since the discovery of penicillin, many other antibiotics were discovered including 
cephalosporins, carbapenems, aminoglycosides, macrolides and fluoroquinolones which 
provided a stepping stone to revolutionising medicine. However, the time after the 1980s 
presents a discovery void with no novel antibiotics discovered (WHO, 2014). Despite 
this, there has been a significant increase in the use (and misuse) of antibiotics for medical 
and agricultural purposes which has led to antibiotic resistance (ABR). 
 
Microorganisms have mastered adaptation mechanisms involving an array of 
evolutionary advantages that allow them to respond rapidly to changing environments 
(Venter et al., 2017b). Most antimicrobials are produced by other microorganisms; 
however, the speed at which bacteria develop resistance against these antimicrobials is 
astonishing. Antimicrobial resistance (AMR) occurs when microorganisms such as 
bacteria, fungi, viruses, and parasites are no longer affected by compounds that previously 
had lethal action against them (FAO, 2016a). There is little doubt that human activity has 
played a significant role in pushing this evolutionary boundary (Sun et al., 2012; Venter 
et al., 2017b). Although there is significant misuse and/or indiscriminate use of antibiotics 
in the healthcare setting, it is equally important to note that the indiscriminate use of 
antibiotics in animal husbandry has contributed considerably to the emergence of 
antibiotic resistance. In the USA, animal husbandry has been shown to consume twice 
the quantity of medically important antibiotics as humans (O’Neill, 2015). Several other 
countries have been reported to include many last resort antibiotics in animal feed (Van 
Cuong et al., 2016). The term “last resort antibiotic” refers to the last line of effective 
antibiotics against resistant bacteria. Resistance against last resort antibiotics is a serious 
threat as minimal treatment options remain (Cai et al., 2012; Venter et al., 2017b). The 
consequences of ABR are numerous, including failure to treat infections which leads to 
prolonged infections and higher rates of mortality (FAO, 2016b). In Europe and USA, 
infections caused by resistant bacteria have claimed up to 50 000 lives with hundreds of 
thousands of more deaths in other parts of the world (O’Neill, 2015). In 2013, it was 
15 
 
estimated that approximately 214 000 global neonatal deaths were due to resistant sepsis 
infections (Laxminarayan et al., 2016). For healthcare systems, this means that antibiotics 
and other drugs that were previously effective are now inadequate and have lost their 
value (WHO, 2015), consequently increasing healthcare costs.  There are no consistent 
global patterns of ABR. Although each country experiences different major issues, ABR 
is an issue that every country should concern themselves with, irrespective of their income 
levels (O’Neill, 2014). 
 
1.2.2 Use of antibiotics in food animals 
It is estimated that the global annual consumption of antibiotic for use in farmed chickens 
is approximately 148 mg antibiotic per kg of animal produced (Van Boeckel et al., 2015). 
This consumption is often for prophylactic or metaphylactic use as a preventative measure 
against outbreaks among the animals housed in close proximity (Van Boeckel et al., 2015; 
Venter et al., 2017b). However, the estimation of the total annual global consumption of 
antibiotics in agriculture is merely an estimation due to insufficient surveillance and data 
collection in many countries. Despite several international recommendations put forward 
by the World Health Organization (WHO) for surveillance of antibiotic resistance in 
food-producing animals, only a few countries have made initiatives; this excludes South 
Africa (WHO, 2014).  
 
The primary issue to be addressed is not the residual antibiotics in meat but rather, the 
selective pressure exerted by the antibiotics leading to the emergence of MDR pathogens. 
There is a general notion that the use of antibiotics that are not employed in the clinical 
setting are acceptable for use in agriculture as growth promoters and feed additives 
(Poole, 2001). However, this is not the case since resistant pathogens can express efflux 
pumps capable of evading various classes of compounds which can lead to multidrug 
resistance including those used in both animal feed and healthcare. For this reason, the 
use of antibiotics prophylactically and as growth-promoters should be reassessed (Venter 
et al., 2017b).  
 
The use of antibiotics for prophylaxis is defined as the administration of these compounds 
to healthy animals for the prevention of infectious disease. When administered through 
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water and feed, this method may not be as effective as believed due to variation in the 
consumption by individual animals and the number of animals exposed (FAO, 2016a). 
Metaphylaxis is defined as the use of antimicrobials at therapeutic doses administered to 
all animals in a group where only a few animals have experienced infection. This acts as 
a treatment regime for those animals that are infected as well as a preventative measure 
for the unaffected animals that may still be at risk (FAO, 2016a). Like prophylaxis, 
metaphylaxis can be used to medicate large groups of animals through water or feed 
(FAO, 2016a). On the other hand, therapeutic antibiotics are administered to treat active 
bacterial infection in a single affected animal. While even a single dose of an antibiotic 
can stimulate ABR within the microbiota of that animal, the repeated and prolonged use 
of antibiotics to treat recurrent infections poses a risk factor for the emergence of  ABR 
(Kohanski et al., 2010a; Andersson & Hughes, 2014).  The use of antibiotics for 
therapeutic purposes should only be long enough to ensure the elimination of infection in 
afflicted animals. The use of antibiotic growth promoters (AGPs) as feed additives has 
been shown to change the gut microbiota of animals as well as promote the transfer of 
resistance within the animal and environmental microbiome (You & Silbergeld, 2014). 
AGPs are administered at sub-therapeutic concentrations to groups of animals through 
drinking water or feed for long durations to advance growth rates (Wielinga et al., 2014). 
There is inconclusive evidence on whether AGPs provide a significant improvement to 
animal development and the mechanism behind growth promotion is not well understood 
(Lee et al., 2012; FAO, 2016a). Without appropriate biosecurity measures, the effect of 
AGPs could be as low as 1% (Laxminarayan et al., 2016).  
 
1.2.3 Consumption of antibiotics in intensive food-animal production 
The three main animal production systems that exist include land-based intensive 
systems, land-based extensive systems and organic systems (FAO, 2016a). Land-based 
intensive systems involve large numbers of animals housed at high densities usually 
indoors. This intensive livestock production method usually involves the use of 
antibiotics as prophylaxis against infectious diseases for large populations for extended 
durations (FAO, 2016a). Livestock bred for intensive production tend to lack the 
variability of their microbiota and instead share similar colonization patterns with 
particular bacterial species (Schokker et al., 2014). Considering this, as well as the close 
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proximity of livestock in such a production system, it is likely that antibiotic-resistant 
populations of bacteria could outcompete susceptible ones. For these reasons, it is 
possible that intensive production systems that are run with a lack of biosecurity and 
livestock health are faced with the risk of being colonized with pathogenic species of 
resistant bacteria (Zhu et al., 2013a; FAO, 2016a). The expansion of intensive systems is 
expected to increase in future due to the growing global demand for livestock products. 
However, there is potential to reduce the need for antibiotics (and therefore a reduction 
in ABR) in intensive production through biosecurity (FAO, 2016a). Land-based extensive 
systems involve extensive livestock farming that requires low inputs generating low 
outputs. This system may require lower levels of antibiotics, thereby reducing ABR. 
However, considering that this farming method involves high numbers of free-range 
livestock, this may result in high transmission rates of commensal and pathogenic bacteria 
(from the environment/soil) which may not occur as often in intensive systems (FAO, 
2016a, 2013).  Organic production systems generally prohibit the use of antibiotics for 
prophylactic and metaphylactic use, and alternative therapeutics are preferred. Vaccines 
are encouraged for the prevention of disease and infection  (Mazurek et al., 2013; FAO, 
2016a). However, different countries stipulate varying levels of acceptable antimicrobial 
or antibiotic use in organic production systems (FAO, 2016a).  Studies observing the 
levels of ABR in livestock raised through conventional production compared to organic 
production revealed that conventional methods showed higher ABR levels (Mazurek et 
al., 2013). In a summary report drawn up in 2015 by the US Food and Drug 
Administration (FDA), it was stated that the domestic sales and distribution of antibiotics 
approved for use in food animals showed an increase of 24% from 2009 to 2015 (FDA, 
2015). The significant quantities of antibiotics consumed by agriculture are likely one of 
the key driving forces of ABR (Robinson et al., 2016a). 
 
Countries such as Brazil, Russia, India, China and South Africa (BRICS) have adopted 
cost-efficient intensive livestock production systems to meet consumer demands. 
However, these intensive livestock productions rely on antibiotics to maintain animal 
health and productivity. Therefore these transitioning countries are contributing to the 
rise of ABR (Van Boeckel et al., 2015). Intensive livestock production suggests direct 
and indirect contact between animals and humans involved in the production system or 
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residing within the vicinity, thereby influencing the transfer of ABR genes between 
animals, humans and the environment (Rushton, 2010; Van Boeckel et al., 2015). 
Moreover, this system of production generates a substantial amount of waste, much of 
which is disposed of on nearby land which raises the potential of dispersing ABR genes 
to environmental bacteria (Hong et al., 2011). In this way, resistance genes and resistant 
bacteria can spread to farm workers who have the potential to serve as vectors for 
transmission into their communities (FAO, 2016a). 
 
MDR bacteria have been isolated from food animals in these BRICS countries as well as 
in other developing countries where the use of antibiotics as growth promoters are not 
regulated (Maron et al., 2013; Zhu et al., 2013b; Van Boeckel et al., 2015). The absence 
of clear regulations and guidelines on the use of antibiotics in agricultural and livestock 
in low and middle -income countries may contribute to irrational use (Van Boeckel et al., 
2015). The patterns of antibiotic use in agriculture vary from one country to another due 
to many factors including regulatory framework and guidance, financial stability, the 
degree of import and export, population size, culture, education and expertise (FAO, 
2016a). It is important to realise that no country alone can successfully combat ABR by 
acting in isolation. The ease of intercontinental travel today creates an avenue for 
antibiotic-resistant pathogens to spread globally (O'Neill, 2014). The global trade of 
agricultural products has also influenced the dissemination of bacteria and therefore the 
spread of ABR globally (Finley et al., 2013). Many countries are under pressure to 
intensify agricultural production rates to meet export demands. However, international 
trade requirements may influence more cautious use of antibiotics in exporting countries. 
Despite this apparent caution, importing countries are still at potential risk of importing 
resistant bacteria selected for by the antibiotics used in the exporting country (FAO, 
2016a). The developing economies of BRICS are likely to contribute to changing global 
patterns. In order to meet the export demands and explore new global markets, there is 
likely to be an increase in antibiotic use to maintain livestock health and productivity 
(FAO, 2016a). In this way, the global spread of ABR can occur rapidly. Furthermore, live 
animals are also traded for breeding or slaughter purposes, and this presents another 
pathway of transmission since livestock harbour a reservoir of bacteria in their 
gastrointestinal tract which is continually mixing and being excreted (FAO, 2016a).  
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1.2.4 One health approach 
In  2015, the WHO released a Global Action Plan (GAP) on AMR (WHO, 2015). The 
WHO has formed a tripartite alliance with the Food and Agricultural Organization of the 
United Nations (FAO) as well as the World Organization for Animal Health (OIE) to 
combat the burden of ABR (This tripartite has since been expanded to include the United 
Nations Environmental Programme). The GAP emphasises the need for an effective “one 
health” approach which includes coordination of numerous international sectors, 
including human and veterinary medicine, agriculture, finance, environment, and well-
informed consumers (WHO, 2015).  The One Health approach recognises that there are 
interlinking connections between the health of people, animals and the environment 
(Robinson et al., 2016a). Antibiotics used in animal health are often analogues of those 
used in human health, which in turn can serve as a driving force for the dissemination of 
resistance determinants between animals and humans through the environment. Human 
health generally takes priority with the global burden of ABR estimated in several reports 
(O’Neill, 2016; WHO, 2014), including specific reports such as those reporting the 
estimated 111 523 neonatal deaths in 2013, resulting from sepsis, that occurred in five of 
the leading countries in which neonatal deaths occur (India, China, Democratic Republic 
of Congo, Nigeria and Pakistan) (Laxminarayan et al., 2016). In contrast, such attention 
has not been drawn to the global burden of ABR in animal health with exact figures and 
data unavailable. However, the global estimation of antibiotic consumption in animals 
seems to exceed that of humans, suggesting that animal production is a significant driver 
of ABR (Robinson et al., 2016a). Unfortunately, the global crisis of ABR is often 
questioned, as there are those that argue that animal-associated infections are rarely seen 
in humans (Chang et al., 2015). However, there is evidence that is connecting ABR in 
animals to ABR in the clinical setting (Robinson et al., 2016b). The use of antibiotics in 
animal feed at sub-therapeutic doses, for prolonged durations, provides the ideal 
conditions for the selection of drug-resistant pathogens (Robinson et al., 2016a). 
Resistance genes arising in animals can be conveyed to human-adapted pathogens or the 
natural gut microbiota through food, people or the environment. Numerous infections that 
occur in people are derived from the natural human gut microbiota. Environmental 
microbes, due to their ubiquity, may also serve as reservoirs of resistance genes for animal 
and human pathogens. This might be influenced by antibiotic residues dumped into the 
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environment originating from the clinical, pharmaceutical and agricultural industry 
(Robinson et al., 2016a). Additionally, a significant proportion of microbial biomass is 
present in the soil, which is also a source from which many antibiotics have been 
discovered and used in medicine (D’Costa et al., 2007). The soil microbial biomass has 
been responsible for the production of various antibiotics, globally, for an estimated 2 
billion years (D’Costa et al., 2011). It is, therefore, proposed that soil can also serve as a 
reservoir of ABR where resistance is naturally occurring. However, the link between 
resistance human-made, clinical antibiotics and naturally produced antibiotics in soil 
remains unclear (Woolhouse et al., 2015). 
 
1.2.5 Intrinsic and Acquired Resistance 
The genomes of bacteria are comprised of chromosomal DNA and accessory genetic 
elements such as plasmids, transposons, insertion sequence common regions, integrative 
and conjugative elements, gene cassettes and integrons (Stokes and Gillings, 2010). 
Chromosomal DNA encodes the genetic information dictating the life cycle of the 
bacterium whereas accessory genetic elements are expressed under specific 
circumstances where they may confer a survival advantage, such as antibiotic resistance. 
Chromosomal DNA is inherited vertically by all members of the bacterial progeny while 
the genetic elements can be transmitted to other bacteria.  Due to this, ABR can be 
inherited intrinsically or via acquired resistance (Courvalin, 2008; Prescott, 2008).  
 
Intrinsic resistance is generally shared by all bacteria of the same genus or species as a 
result of chromosomal genes that are associated with the physiological characteristics of 
the bacteria. It can also be described as natural resistance. As a result of environmental 
stress, bacteria are also able to initiate adaptive resistance which can activate ABR 
phenotypes. This type of resistance can lead to active efflux mechanisms or diminished 
permeability of an antibiotic (Courvalin, 2008). The distinguishing factor between 
adaptive resistance and intrinsic resistance is the fact that the adaptive resistance 
disappears in the absence of the stimulus. Acquired resistance allows bacteria to develop 
resistance using a variety of methods including vertical transmission and horizontal gene 
transfer. Vertical transmission of resistance happens when mutations occur in the 
structural or regulatory chromosomal genes which are then inherited by the bacterial 
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progeny (Courvalin, 2008). Structural genes may undergo mutations in the regions that 
encode antibiotic targets, such as proteins against which antibiotics act. These target 
mutations depend on the mode of action of an antibiotic compound, and regulatory 
mutations can occur spontaneously, often altering gene expression (Courvalin, 2008). 
 
Horizontal gene transfer can be described as a mechanism of gene transmission which 
may occur via one of the following events:  (1) transformation, whereby a competent 
bacterial cell can incorporate free DNA into the cell; (2) transduction, where a 
bacteriophage acts as a vector transporting DNA from one bacterial cell to another and 
finally, (3) conjugation, which involves the transfer of DNA from a donor to a recipient 
bacterial cell via cell-to-cell contact (Courvalin, 2008; Kelly et al., 2009). Horizontal gene 
transfer can arise through the transfer of a single resistance determinant or multiple 
resistance determinants that are incorporated into mobile genetic elements. Mobile 
genetic elements refer to determinants such as gene cassettes which insert into integrons 
which in turn combine into transposons and these transposons incorporate into plasmids 
(Kelly et al., 2009). This dynamic action of integration and transposition allows for the 
union of multiple resistance determinants into a single genetic element with the ability to 
regulate gene expression through rearrangement (Amábile-Cuevas, 2013; Mazel, 2004). 
The mobility of integrons is also influenced by the presence of antibiotics and these 
genetic elements are often co-expressed from one promoter enabling activation of various 
resistance determinants (Mazel, 2006).  
  
1.2.6 Enterococcus spp.: commensals and pathogens 
Enterococci are natural inhabitants of the gastrointestinal tract (GIT) of humans and 
animals.  They can also be found in food, water and soil. Enterococci may account for  
>0.1% of a human adult microbiota and can be considered both commensals and 
opportunistic pathogens (Schloissnig et al., 2012; de Lastours et al., 2017). There are 
approximately 57 species of Enterococcus to date 
(http://www.bacterio.net/Enterococcus.html). These Gram-positive facultative anaerobes 
have a particular ability to survive under harsh conditions such as high salt concentrations, 
various pH values and temperatures ranging from 10°C to more than 45°C (Arias & 
Murray, 2012), making it challenging to control the spread of pathogenic strains. 
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Enterococcus spp. are the second leading cause of nosocomial infections, globally (Khan 
et al., 2015). Enterococcus gallinarum and Enterococcus casseliflavus are responsible for 
a minority of clinical infections while Enterococcus faecium and Enterococcus faecalis 
are among the most notorious nosocomial pathogens (Giraffa, 2014). These 
microorganisms are well known for being the common cause of endocarditis and a range 
of other infections including pelvic infections, neonatal infections and urinary tract 
infections (UTIs) (Arias & Murray, 2012). In the global context, approximately 10% of 
adult bloodstream infections can be attributed to enterococci with about 65-70%  being 
due to E. faecalis, while E. faecium accounts for approximately 25% (Falcone et al., 
2015). It is also estimated that 10% of neonatal bloodstream infections are caused by 
enterococci, with meningitis being an occasional resultant complication (Haslam & St. 
Geme, 2018). Patients that are of particular risk for invasive enterococcal infection 
include immune-compromised individuals, haemato-oncology and transplant patients 
(Humphreys, 2014).  
 
E. faecalis and E. faecium may be grouped into distinct clonal complexes (CC) based on 
their enhanced ability to disperse in nosocomial environments. Furthermore, E. faecium 
can be further distinguished into clades: isolates that are hospital-adapted (clade A, such 
as CC17) and those that are commensals (clade B) (Palmer et al., 2012). It is of particular 
interest to discern whether clinical isolates of E. faecium and E. faecalis are genetically 
similar than isolates from animals. It has been shown that clinical clonal complex isolates 
such as CC5, CC2 and CC17 are not only confined to nosocomial settings since these 
strains were also identified in pigs (Freitas et al., 2011).  
 
1.2.7 Agricultural contribution to the rise of ABR in Enterococcus 
A large proportion of antibiotics are used for food animal production. In 1988, the 
chemically structural analogue of vancomycin called avoparcin was introduced as an 
AGP in chickens and pigs in Denmark. Studies conducted in 1995 reported that VRE 
were present in about 80% chickens that were exposed to avoparcin, whereas no VRE 
were detected among organically farmed chickens (Aarestrup, 1995). This was an 
indication that the use of avoparcin as an AGP influenced the rise of VRE (Aarestrup et 
al., 1996).  In 1995 Denmark implemented a ban on the use of avoparcin as a growth 
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promoter, even so, VRE remained present in pigs at a frequency of 20% for some time 
after this period (Aarestrup et al., 2000a; DANMAP, 2014). It was only after the 
subsequent ban of tylosin (a macrolide) that the persistence of VRE decreased (Aarestrup 
et al., 2000a). This can be explained by the fact that the genes encoding vancomycin and 
tylosin resistance are located in close proximity on the same plasmid, hence co-selection 
(Aarestrup et al., 2000a). In Europe, the use of vancomycin in the clinical setting was 
limited while the use of avoparcin was approved as an AGP. Conversely, in the USA, 
avoparcin was banned as an AGP while vancomycin was in high demand for clinical use. 
However, the prevalence of VRE incidence was confined among clinical populations in 
the USA compared to Europe. It is likely that VRE were confined to hospitals in the USA 
while VRE from animal sources were able to penetrate human communities and therefore 
enter the hospital setting (Wielinga et al., 2014; Coque et al., 1996).  
 
In Sweden, avoparcin was used in food animals for a short duration between the late 
1970s and early 1980s after which it was quickly banned along with all growth promoters 
(Nilsson, 2012). In subsequent years, the prevalence of VRE increased from 1% in 2000 
to 40% in 2005, for reasons that are unknown (Nilsson et al., 2009). Jansson et al. (2012) 
sought to investigate the persistence of vancomycin-resistant E. faecium (VREfm) within 
the barns of 12 Swedish poultry farms, between flocks, and to decipher if day-old chicks, 
poultry feed and forklift trucks were a source of contamination. The results concluded 
that 75% of environmental samples from 9 farms were positive for VREfm before 
cleaning and disinfection while 31% of farms were VREfm-positive following cleaning 
and disinfection. Furthermore, pulse-field gel electrophoresis (PFGE) analysis revealed 
similar, or indistinguishable banding patterns of isolates between farms investigated, 
suggesting clonal dissemination via transport crates, farm workers or even water as 
vectors for transmission. It was also noted that broiler feed and hatcheries were not a 
significant source of VREfm while strains were found on two forklift trucks’ tyres despite 
disinfection. PFGE banding patterns showed that isolates from the farms and the forklift 
were indistinguishable, strongly indicating the forklift as a source of contamination 
between farms. This study brings attention to the need for VRE surveillance to estimate 
the risk of transmission not only between farms but the possibility of these clones also 
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entering the community and clinical setting where crucial resistance determinants may 
circulate.  
 
Virginiamycin, a streptogramin antibiotic has been used across the world, including the 
European Union (EU), as a feed additive, growth promoter and preventative measure 
against coccidiosis and enteritis in chickens. In 1997, vancomycin resistant E. faecium, 
also showing quinupristin-dalfopristin, resistance was isolated from chicken samples and 
a hospital patient in the United Kingdom (Woodford et al., 1997). However, the 
streptogramin quinupristin-dalfopristin was not approved in the United Kingdom for 
clinical use at the time despite its activity against vancomycin-resistant E. faecium. 
Quinupristin-dalfopristin resistance found outside the clinical setting was suggested to be 
associated with the use of virginiamycin in food animals (Hammerum et al., 2010; 
Aarestrup et al., 2000b). Following several studies linking streptogramin resistance genes 
isolated from food animals and hospital patients, in 1998 the EU banned the use of 
virginiamycin (Hammerum et al., 2010). Still, the use of virginiamycin for growth 
promotion and therapy continues in several countries across the world.  
 
Gentamicin has been used in the EU for therapy in food and companion animals. 
However, the emergence of high-level gentamicin resistance in poultry, several other 
food and companion animals and healthy humans quickly drew attention (Hammerum et 
al., 2010) because gentamicin and other aminoglycosides are used in combination therapy 
with β-lactams to combat VRE infections (Hammerum et al., 2010). In past studies, it 
was shown that the genes responsible for high-level gentamicin resistance in humans were 
also present in the meat of food animals (Donabedian et al., 2003).  
 
Heavy metals used as growth promoters in animal feed can also favour the selection and 
spread of antibiotic resistance. Copper (Cu) and zinc (Zn) are commonly used in animal 
feed, at higher concentrations than metabolically required, as a substitute for antibiotics 
(Monteiro et al., 2010). Resistance to Cu in enterococci is commonly attributed to the 
presence of the plasmid-borne tcrB gene, which has a link to the erythromycin resistance 
gene ermB and glycopeptide resistance gene vanA (Hasman & Aarestrup, 2002). This is 
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indicative that Cu-resistant enterococci may serve as a reservoir and risk for the spread 
of erythromycin and vancomycin resistance genes.  
 
1.2.8 Mechanisms of antibiotic resistance in Enterococcus spp. 
Enterococci have intrinsic resistance to numerous antibiotics including cephalosporins, 
lincosamides and streptogramins in addition to low-level aminoglycoside resistance 
(Hollenbeck & Rice, 2012). Additionally, these resilient microorganisms are equipped to 
acquire an array of antibiotic resistance genes via horizontal gene transfer or sporadic 
mutations.  
 
Invasive infections caused by Enterococcus spp. are often treated with a combination of 
a β-lactam antibiotic (e.g., penicillin) and an aminoglycoside (e.g., gentamicin) or a 
glycopeptide such as teicoplanin or vancomycin (Hammerum et al., 2010). Vancomycin 
is among the last resort antibiotics against Gram-positive bacteria (Schmidt, 2011).  The 
rise in antibiotic resistance among enterococci is a cause for concern, especially with the 
rise of VRE which is mainly associated with E. faecium (Santajit & Indrawattana, 2016). 
Furthermore, Enterococcus spp. may also serve as a reservoir of vancomycin resistance 
genes to more pathogenic Gram-positive bacteria such as methicillin-resistance 
Staphylococcus aureus (MRSA) (Chang et al., 2003). Mechanisms of resistance to 
enterococcal-relevant antibiotics are discussed in the following section.  
 
1.2.8.1 Resistance against cell wall inhibitors 
β-lactams 
Penicillins are β-lactams that have bacteriostatic activity against enterococci and when 
combined with aminoglycosides, provide a synergistic and bactericidal effect. Ampicillin 
and penicillin are among the most potent agents within the β-lactam arsenal of antibiotics 
that are active against enterococci. Their mechanism of action is through the inhibition of 
cell wall biosynthesis. The bacterial cell wall is composed of peptidoglycan which serves 
as an “armour” enabling bacteria to endure mechanical stress. Peptidoglycan consists of 
cross-linked glycan chains of alternating N-acetylglucosamine, and N-acetylmuramic 
acid (Sychantha et al., 2018) Penicillin-binding proteins (PBPs) are the workhorses of 
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cell wall biosynthesis as they catalyse the polymerisation and crosslinking of glycan 
chains through transglycosylation and transpeptidation, respectively (Sauvage et al., 
2008). All enterococci produce at least five PBPs. E. faecalis and E. faecium possess six 
putative PBP genes (Sahare & Moon, 2014; Duez et al., 2004) Intrinsic tolerance of 
enterococci to β-lactams can be attributed to the presence of chromosomally encoded 
pbp5 which allows low binding affinity for ampicillin and cephalosporins (Sifaoui et al., 
2001). E. faecium harbours pbp5 on an operon with two other genes: psr, a repressor of 
PBP synthesis and ftsW which interacts with PBP3 of Escherichia coli (Rice et al., 2001).  
High-level penicillin resistance can be attributed to mutations in the PBP5 receptor 
region, resulting in a decreased binding affinity for the drug (Suleyman & Zervos, 2016). 
 
The presence of β-lactamase activity against ampicillin, through disruption of the β-
lactam ring, has been documented in both E. faecalis and E. faecium (Murray, 1992). This 
system of resistance (initially described in Staphylococcus aureus) can be attributed to 
the presence of the gene blaZ which encodes a β-lactamase as part of an operon consisting 
of blaR1 and blaI which encode a signal transducer and a repressor, respectively 
(Hackbarth & Chambers, 1993; Sarti et al., 2012). The blaZ gene is expressed 
constitutively and at low levels in enterococci. During routine susceptibility testing, 
where the enterococcal inoculum concentration is ~1 × 105 cells per ml, the enzyme is 
produced at a negligible level and hence the culture tests susceptible. However, during 
infection, where the inoculum concentration is high, the enzyme is present at higher levels 
resulting in resistance (Miller et al., 2015).  
 
Ampicillin resistance is more common in E. faecium as opposed to E. faecalis, and its’ 
prevalence in poultry is often geographically dependent. In Denmark, the prevalence of 
ampicillin-resistant E. faecium is more frequent in imported broiler meat, while in the 
USA it is more frequent in turkey meat rather than chicken meat (Bortolaia et al., 2016). 
Martins et al., (2015) investigated the presence of ampicillin-resistant E. faecium from 
non-clinical sources in Angola. Resistant isolates were recovered from poultry with one 
isolate showing a PBP5 sequence similar to previously isolated clinical strains. This 
suggests that the use of β-lactams in the animal sector provided selective pressure for the 




Glycopeptides such as vancomycin, teicoplanin and other derivatives are among the 
critical antibiotics used for the treatment of Gram-positive bacterial infections (Kristich 
et al., 2014). Glycopeptides act by inhibiting peptidoglycan biosynthesis by forming 
complexes with the D-Ala-D-Ala peptide terminus of peptidoglycan precursors located 
on the outer surface of the cell. This obstructs cell wall biosynthesis enzymes from using 
these precursors which ultimately compromises the integrity of the cell wall (Kristich et 
al., 2014). Enterococci evade the action of glycopeptides by altering the drugs’ target, 
usually by substituting the D-Ala-D-Ala termini with D-Ala-D-Lactate or D-Ala-D-Ser. 
Such substitutions significantly reduce the binding affinity of glycopeptides to the 
peptidoglycan precursors, thereby allowing cell wall biosynthesis to continue unhindered. 
Substitution with D-Ala-D-Lac results in a 1000-fold decrease in binding affinity for 
vancomycin while substitution with D-Ala-D-Ser only results in a 7-fold decreased 
binding affinity, and therefore a lower resistance level to vancomycin (Cattoir & 
Leclercq, 2013). Resistance operons which are generally encoded on mobile genetic 
elements allow production of these altered peptidoglycan precursors. Glycopeptide 
resistance may also be encoded in chromosomal DNA as part of the core genome of 
enterococci (Kristich et al., 2014).  
 
There are nine gene clusters that have been identified in enterococci that confer 
glycopeptide resistance: vanA, vanB, vanC, vanD, vanE, vanG, vanL, vanM and vanN 
(Raza et al., 2018). The vanA and vanB are the most commonly observed clusters in 
clinical isolates of enterococci (Tzavaras et al., 2012). The vanA phenotype confers high-
level resistance to both vancomycin and teicoplanin. The vanA determinant is often 
plasmid-borne on the transferable transposon Tn1546 or similar transposons. The vanA 
gene functions in conjunction with several other genes such as vanR, vanS, vanH, vanX, 
vanY and vanZ to confer resistance (Raza et al., 2018). VanR and VanS form a two-
component regulatory system which is transcribed from one promoter while the 
remaining genes are transcribed from a second promoter. vanR and vanS encode a 
response regulator and a sensor kinase, respectively. The VanS sensor kinase identifies a 
stimulus that signals the presence of vancomycin in the environment which prompts 
activation and autophosphorylation of VanS on the cytoplasmic side of the protein. The 
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phosphoryl group can be transferred from the conserved histidine region of VanS to a 
conserved aspartate residue on VanR. This results in the dimerisation of VanR which 
therefore enhances VanR binding to the two promoters on the van operon, ultimately 
leading to up-regulated transcription of both van resistance and regulatory genes 
(Depardieu et al., 2005). vanA encodes a ligase that forms the D-Ala-D-Lac dipeptide 
while vanH encodes for a dehydrogenase that converts pyruvate to lactate. Both these 
gene products play crucial roles in the production of modified peptidoglycan precursors 
to evade the action of glycopeptides.  In order to eliminate any remaining normal 
peptidoglycan precursors, the vanX and vanY genes encode gene products to allow for 
efficient removal: vanX encodes dipeptidase that cleaves D-Ala-D-Ala residues while 
VanY encodes a D,D-carboxypeptidase. The function of the vanZ determine remains 
poorly understood (Kristich et al., 2014). 
 
vanB confers moderate to high level of resistance to vancomycin only. This phenotype is 
still susceptible to teicoplanin. The vanB determinant can be located on Tn5382 or 
Tn1549 type transposons which may be harboured on plasmids or form part of the core 
genome (Kristich et al., 2014). The arrangement of the vanB genes is similar to vanA 
since it also contains two promoters and seven open reading frames. However, while vanB 
encodes for a two-component system (consisting of VanRB and VanSB), the way this 
signalling system functions is different from vanA. The vanS and vanSB show minimal 
sequence similarity in the N-terminal domain responsible for stimulus recognition. vanB 
encodes homologs of VanH, VanX and VanY (Kristich et al., 2014; Depardieu et al., 
2007). However, the vanB operon lacks the vanZ gene and instead encodes a protein 
designated VanW which has not clearly been defined (Kristich et al., 2014). 
 
The vanC-type resistance gene is an intrinsic, chromosomally-encoded gene commonly 
found in E. gallinarum and E. casseliflaus which produces the modified peptidoglycan 
precursor D-Ala-D-Ser (Reynolds & Courvalin, 2005). The vanC1 gene is a feature of E. 
gallinarum whereas vanC2/3 is found in E. casseliflavus. This feature confers low-level 
vancomycin resistance through the production of D-Ala-D-Ser using the VanT serine 
racemase (Meziane-Cherif et al., 2015). Studies have shown that the vanC phenotype is 
not limited to E. gallinarum and E. casseliflavus as many reports show its presence in E. 
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faecalis and E. faecium (Schwaiger et al., 2012; Nishiyama et al., 2015). Tzavaras et al. 
(2012) investigated the prevalence of VRE in broiler production after the ban of avoparcin 
and their link to human clinical VRE in Greece. It was shown that 22.6% of isolates were 
VRE-positive and the vanA gene was the predominant resistant determinant recovered 
from VRE originating from broiler sources. Despite the ban of vancomycin analogues 
such as avoparcin, VRE seemed to persist without glycopeptide selective pressure. This 
suggests that the extensive use of other antibiotics may create a selective pressure for the 
co-selection of glycopeptide resistance determinants, enabling the persistence of VRE; 
such as the genetic link between macrolide and vancomycin resistance (Tzavaras et al., 
2012). This study further reported the results of PFGE which indicated that VRE from 
broiler and human sources were clustered according to their source which strongly 
suggested against the clonal spread of isolates.  
 
Daptomycin  
Daptomycin is a lipopeptide antibiotic that disrupts the structure of the bacterial cell 
membrane. The bacterial cell membrane serves as a structural and functional component 
by regulating cellular processes that involve interaction between the cell’s external and 
internal environments. Daptomycin acts by inserting into the bacterial cell membrane in 
the presence of calcium ions and oligomerizes to form a pore structure that jeopardises 
the integrity of the bacterial cell membrane. This leads to reduced functionality of the 
bacterial cell membrane as many processes become disrupted causing leakage of ions and 
ultimately leading to cell death (Miller et al., 2015; Steenbergen et al., 2005). Enterococci 
appear to be less susceptible to this antibiotic as compared to staphylococci (Cantón et 
al., 2010). In 2011, Arias and colleagues  reported that mutations in the following genes 
were necessary for daptomycin resistance: genes encoding a putative cell membrane 
protein, LiaF and a GdpD-family protein involved in phospholipid metabolism. LiaF is 
thought to form part of the three-component regulatory system designated LiaFSR (lipid-
II interacting antibiotics) which functions in stress response of the cell envelope to 
antibiotics (Arias et al., 2011). Since strains of E. faecium are commonly multidrug-
resistant, daptomycin is often used as the first line of defence. Therefore, daptomycin 
resistance appears to be more prevalent in E. faecium compared to E. faecalis. The genetic 
basis of daptomycin resistance in E. faecium appears to be different from E. faecalis 
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(Miller et al., 2015). Whole genome analysis of a clinical daptomycin-resistant strain of 
E. faecium revealed that resistance was associated with mutations in eight genes, 
including those involved with phospholipid metabolism and associated with E. faecalis 
resistance (Tran et al., 2013). The eight genes responsible for resistance include those 
encoding YycFG proteins which form part of a two-component regulatory system (yyc 
system). The YycF serves as the response regulator while YycG functions as the histidine 
kinase sensor. This system functions to modulate cell wall homeostasis during cell 
division. The authors of the study speculate that the Yyc system in E. faecium is an 
alternative pathway to the LiaFSR to signal cell envelope changes due to antibiotics, and 
therefore it is associated with the rise of daptomycin resistance (Tran et al., 2013). 
However, the LiaFSR system has also been implicated in daptomycin resistance in E. 
faecium. Analysis of genomes of several E. faecium isolates showed that the most 
frequently encountered mutations associated with resistance lay within the liaFSR genes 
followed by mutations in the YycFG system (Diaz et al., 2014).  
 
Very few studies focus attention on daptomycin resistant enterococci in poultry, possibly 
since there are several debates whether daptomycin is clinically superior to linezolid for 
treatment of VRE (Chuang et al., 2016). Furthermore, no distinct clinical breakpoints 
have been established for daptomycin resistance in enterococci (de Jong et al., 2018). 
Nevertheless, it is essential to monitor the resistance situation in food animals to help 
predict future possibilities, since this drug is among the last line of clinical treatment for 
VRE. Few studies that have included daptomycin in the panel of antibiotics, when 
investigating the prevalence of antibiotic resistance in poultry, have reported no 
daptomycin resistance in the enterococcal isolates recovered (de Jong et al., 2018; Aslam 
et al., 2012).  
 
1.2.8.2 Resistance against antibiotics that hinder protein synthesis 
Aminoglycosides 
Aminoglycosides have concentration-dependent bactericidal activity and target the 16S 
rRNA of the 30S ribosome (Hermann, 2007). This class of drugs are actively transported 
into the cell cytosol where they reach the 30S ribosome target, leading to disruption of 
protein synthesis and ultimately cell death (Feldman et al., 2010). Aminoglycosides are 
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often coupled with β-lactam antibiotics, such as ampicillin, which increase the cell wall 
permeability and thereby increases the aminoglycoside uptake thereby enhancing the 
death of enterococci (Chow, 2000). While intrinsic low-level aminoglycoside resistance 
genes reside within the genome of enterococci, high-level resistance is often attributed to 
the acquisition of genes encoding aminoglycoside-modifying enzymes (AMEs) 
(Padmasini et al., 2014; Costa et al., 1993) in tandem with the reduced uptake of the 
antibiotic. Enzymatic inactivation of the drug occurs through covalent modification of 
the aminoglycoside thereby causing reduced binding affinity for the ribosomal target. 
AME’s can be classified into three groups: N-acetyltransferase (AAC - responsible for 
catalysis of acetylation of an amino group), O-adenylyltransferase (ANT – catalyses 
adenylation of hydroxyl groups) and finally O-phosphotransferase (APH – for the 
phosphorylation of hydroxyl groups) (Shete et al., 2017). Those of highest concern are 
those that hinder the activity of gentamicin and streptomycin since these are commonly 
used for the synergistic treatment of enterococcal infections (Hollenbeck & Rice, 2012). 
High-level gentamicin resistance is generally mediated by aac(6’)-Ie-aph(2”)-Ia while 
high-level streptomycin and kanamycin resistance is mediated by aph(3’)-IIIa 
(Kobayashi et al., 2001). Enterococci are also able to modify the antibiotic target, such as 
ribosomal RNA (rRNA) through the activity of the methyltransferase enzyme designated 
EfmM (Galimand et al., 2011). This enzyme acts by methylating a specific cytidine 
residue of the 16S rRNA in E. faecium which hinders the binding of kanamycin and 
tobramycin, thereby conferring resistance (Galimand et al., 2011).  
 
Choi & Woo ( 2013) investigated high-level gentamicin-resistant (HLGR) E. faecalis 
from chicken meat in Korea and demonstrated that all HLGR strains harboured the 
aac(6’)-Ie-aph(2”)-Ia gene. Multilocus sequence typing (MLST) revealed that several 
sequence types corresponded to clinical sequence types in the MLST database. This 
suggests that chicken products could be a reservoir of HLGR enterococci that may 
circulate through the food chain.  
 
Oxazolidinones   
Linezolid is a synthetic, bacteriostatic agent that inhibits protein biosynthesis in Gram-
positive bacteria. Its mechanism of action is through blockage of the 23S rRNA site 
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required for docking of aminoacyl-tRNA in the A site of the ribosome (Leach et al., 2007) 
Bacterial resistance to linezolid may arise through point mutations in genes encoding the 
23S rRNA which serves as the primary drug binding site of the ribosome. Enterococci 
encode several copies of the 23S rRNA gene which can be correlated with the resistance 
phenotype. Specifically, the level of resistance has been correlated with the number of 
23S rRNA genes possessing a G2576U mutation in the domain V of 23S rRNA (Long et 
al., 2010). Mutations in ribosomal proteins such as L3 and L4, initially described in 
staphylococci may also contribute to linezolid resistance (Locke et al., 2009; Chen et al., 
2013). Enzymatic modification of the 23S rRNA through methylation of an adenine 
residue due to a methylase denoted as Cfr has been found in clinical isolates of E. faecalis 
and some strains of S. aureus. The cfr gene is harboured on a plasmid and often associated 
with the mobile genetic element, IS256 (Hennig & Ziebuhr, 2010). The V IS256 has been 
implicated in the transfer of antibiotic resistance genes as well as influencing the 
activation of expression of existing resistance determinants (Hennig & Ziebuhr, 2010). 
In 2015 in China, Wang et al.  reported on the novel plasmid-borne ABC transporter gene 
optrA that conferred multiple resistance to oxazolidinones and phenicols. The authors 
also observed that the novel gene shared residence with the fexA, on a conjugative 
plasmid, which confers resistance to phenicols. This novel resistant determinant was more 
prevalent in E. faecalis, and E. faecium isolates from food animals (pigs and chicken) as 
compared to those of human origin. This study demonstrated the importance of testing 
not only for cfr and 23S rRNA mutations but also for the optrA gene.  However, optrA is 
not limited to its discovery in China and has also been reported for the first time in poultry 
meat in America (Cavaco et al., 2017). The authors of this American study aimed to 
reevaluate previously isolated linezolid-resistant enterococci of poultry origin that were 
devoid of the cfr gene and 23S rRNA mutations. This re-examination of the whole 
genome sequencing data revealed the presence of optrA.  
 
Macrolides, lincosamides and streptogramins (MLS) 
These are three functionally similar but chemically distinct antibiotics. MLS antibiotics 
fall under the group of 50S ribosome inhibitors and exert inhibition against the initiation 
of protein translation or by hindering translocation of peptidyl-tRNAs, thereby halting 
the elongation of a nascent peptide chain (Kohanski et al., 2010b). Macrolides such as 
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tylosin are often recommended for veterinary use in the treatment of respiratory infections 
in cattle, swine and poultry (Marosevic et al., 2017).  
 
Enterococci often present with cross-resistance to macrolides, lincosamides and 
streptogramin B, known as the MLSB phenotype. This is commonly associated with 
methylase genes, such as ermB, which dimethylates an adenine residue on 23S rRNA 
which inhibits binding of the three drugs (Portillo et al., 2000; Weisblum, 1995). 
Macrolide resistance is also conferred by efflux pump systems encoded by mef and msr 
genes (Portillo et al., 2000).  The MLSB phenotype conferred by the erm genes provides 
resistance to quinupristin, which is a streptogramin B, while dalfopristin (streptogramin 
A) retains its activity. In addition to this phenotype, there exists the LSAP phenotype 
which confers resistance to lincosamides, streptogramin A and pleuromutilins. 
Pleuromutilins are a class of protein inhibitors that share ribosomal binding sites with the 
MLS antibiotics (Novak & Shlaes, 2010). While E. faecalis shows intrinsic LSAP 
resistance with the production of an ABC homologue, this phenotype may be selected in 
vivo in E. faecium upon exposure to quinupristin-dalfopristin (QD) (Dowzicky et al., 
2000). E. faecium exhibits resistance to streptogramin B antibiotics through the 
expression of efflux pumps encoded by msrC genes (Portillo et al., 2000). A recent study 
that investigated the genetic basis of resistance in E. faecium in France  showed that a 
mutation in the E.faecium ABC transporter gene, eatA, conferred LSAP-type resistance to 
susceptible strains (Isnard et al., 2013). This gene is thought to be unique E. faecium 
strains and shows amino acid sequence similarity to proteins conferring LSAP-type 
resistance in other Gram-positive bacteria (Isnard et al., 2013).  
 
QD is a combination of semisynthetic streptogramins, streptogramin A (dalfopristin) and 
streptogramin B (quinupristin). QD shows effective activity against E. faecium including 
vancomycin-resistant strains (Hershberger et al., 2004). The dalfopristin component 
induces a ribosomal conformational change which exposes the high-affinity binding site 
for quinupristin, thereby inducing irreversible inhibition of the ribosome (Canu & 
Leclercq, 2001). QD-resistance can arise through one of several mechanisms: enzymatic 
modification of the antibiotic, efflux of the drug out of the cell via ATP-binding proteins 
and alteration of the antibiotic target site. A streptogramin A resistance gene (vat or vga) 
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is needed to confer resistance to QD. Streptogramin A resistance genes, encoding 
acetyltransferase, commonly harboured by E. faecium include vatD and vatE. It has been 
reported that vatE has been commonly recovered from poultry farms, retail poultry and 
human origin (Donabedian et al., 2006). Also, E. faecium harbours lactonases, VgbA and 
VgbB, which cleaves the ring structure of streptogramin B thereby conferring resistance 
(Korczynska et al., 2007). E. faecalis displays intrinsic resistance to QD owing to the 
presence of the lsa gene (lincosamide and streptogramin A resistance) which is thought 
to encode a putative ATP-binding protein (Singh et al., 2002). Although the exact 
mechanism of resistance is not well understood, it is assumed that it is the result of active 
efflux of the drugs (Singh et al., 2002).  
 
Tetracyclines  
Tetracyclines are broad-spectrum antibiotics active against a wide range of Gram-positive 
and Gram-negative bacteria, in addition to several other microorganisms. Tetracyclines 
primarily target the ribosome and act by preventing the attachment of charged aminoacyl-
tRNA to the ribosomal acceptor A-site. This inhibits protein synthesis by hindering the 
addition of new amino acids to the nascent peptide chain (Chopra & Roberts, 2001). The 
low cost of these antibiotics, especially chloro-tetracyclines, has prompted widespread 
veterinary use for the treatment of a variety of infections (Chopra et al., 1992). Bacteria 
have adopted four main mechanisms of tetracycline resistance: efflux, ribosomal 
protection, degradation of the drug and rRNA mutations with efflux being the most 
prevalent mechanism (Nguyen et al., 2014). Ribosome protection proteins, of which 12 
have been identified, bind to the tetracycline target site on the ribosome thereby hindering 
the drug’s mode of action. Tetracycline degradation can be achieved by two rarely 
encountered genes encoding mono-oxygenases (tetX and tet37). Finally, mutations within 
16S rRNA confer reduced binding affinity for tetracycline to the ribosome (Nguyen et 
al., 2014). Efflux pumps may be encoded by genes such as tetK or tetL while ribosomal 
protection proteins are encoded by tetM, tetO, tetT, tetS and tetW. Resistance to 
tetracyclines is commonly mediated by tetM and tetL in isolates of food animal origin 
(Rizzotti et al., 2009; Chopra & Roberts, 2001; Frazzon et al., 2010). It has been reported 
that the co-existence of tetM and tetL enhances antibiotic resistance against doxycycline 
(Schwaiger et al., 2009). Tetracycline resistance is commonly harboured on transposons, 
35 
 
such as tetM which is harboured on Tn916. The Tn916 transposon only harbours tetM 
while Tn1545 harbouring tetM is associated with ermB, conferring erythromycin 
resistance as well (Rice, 1998). In a study carried out by Vignaroli et al. (2011) in Italy, 
enterococcal isolates from pig and chicken meat and faeces were investigated for the 
presence of multiple antibiotic resistance genes and their potential to transfer to human 
strains. More than 80% of isolates were co-resistant to tetracycline and erythromycin, 
harbouring the tetM and ermB genes, which corresponds to the common locations of these 
genes on transposons. Co-transfer of vanA and ermB were mainly detected in E. durans 
isolates of faecal origin suggesting residence on the same transposon. These findings were 
the first to report such resistance patterns in E. durans of farm animal origin and raised 
concerns for possible co-transfer of such resistance genes to clinically relevant 
enterococcal strains (Yahav et al., 2011). 
 
1.2.8.3 Inhibition of folic acid metabolism 
Quinolones 
The founding member of the quinolones class of antibiotics was nalidixic acid, discovered 
in 1962, with use limited to the treatment of urinary tract infection (Lesher et al., 1962). 
Due to its narrow spectrum of activity, newer compounds were sought which led to the 
synthesis of fluoroquinolones. This led to the introduction of norfloxacin followed by 
ciprofloxacin. Quinolones primarily target bacterial topoisomerases – DNA gyrase and 
DNA topoisomerase IV (Hooper, 1998). These enzymes catalyse double-strand break in 
DNA to allow another strand to pass through the break and after that seal the break 
(Aldred et al., 2014). Gyrase is composed of GyrA and GyrB subunits which are 
homologous to ParC/GrlA and ParE/GrlB subunits of topoisomerase IV, respectively 
(Aldred et al., 2014). Quinolone resistance is commonly attributed to amino acid 
substitutions in gyrA and parC genes (Drlica & Zhao, 1997). Since the 1980s, 
fluoroquinolones have been a popular choice for treatment of UTIs caused by E. faecalis. 
However, this has led to an increase in fluoroquinolone-resistant E. faecalis (Lee, 2013). 
The frequent use of fluoroquinolones in animal husbandry for prophylactic and 
therapeutic purposes has also contributed to the rise of resistance to these drugs (Chang 
et al., 2015).  The emergence of high-level ciprofloxacin-resistant (HLCR) strains of E. 
faecalis, and E. faecium has been on the rise with the ease of spread within the clinical 
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setting (Woodford et al., 2003; Valdezate et al., 2009). In 2015, an investigation into the 
antibiotic-resistant characteristics of HLCR E. faecium and E. faecalis isolated from fresh 
produce, and clinical faecal samples from Gyeonggi Province in Korea were compared. 
The aim was to identify relatedness between the two sample groups and determine the 
occurrence of gyrA and parC mutations in the isolates as well as the sequence type. The 
study confirmed mutations within gyrA and parC, from both sample groups, suggesting 
the importance of such mutations in fluoroquinolone resistance. Also, these isolates 
proved to be multidrug resistant and harboured virulence genes suggesting that HLCR 
isolates are highly virulent (Kim & Woo, 2017). Sequence type analysis revealed two 
main CC’s: CC17 and CC87, which were mainly related to outbreaks and clinical 
samples. These results should be considered when investigating HLCR enterococci from 
retail meat such as poultry in terms of antibiotic-resistance and virulence potential. 
Plasmid-borne resistance to fluoroquinolones as a result of qnr genes are generally 
reported in Enterobacteriaceae. These genes encode pentapeptides which hinders 
fluoroquinolone activity against DNA gyrase. A study conducted in Italy investigating 
the role of qnr-like genes in intrinsic resistance of E. faecalis to fluoroquinolones showed 
that such a gene exists in the genome of E. faecalis V583. Inactivation experiments 
showed a two-fold decrease in resistance to fluoroquinolones while overexpression led to 
four- to nine-fold increase in resistance. This suggested that qnr-like genes may serve as 
a new mechanism of enterococcal fluoroquinolone resistance (Arsène & Leclercq, 2007).   
 
1.2.9 Virulence factors and Pathogenesis of Enterococcus spp. 
Virulence can be described as the capacity of a microorganism to infect, colonise and 
cause disease within a host (Schroeder et al., 2017). Genetic virulence factors may 
influence the physical (flagella, biofilm, adhesions) and biochemical attributes (cell 
surface modifying enzymes, toxins) of a bacterium. On the virulence hierarchy, 
Enterococcus species of clinical origin dominate followed by isolates of food origin 
(Busani et al., 2004). The factors that contribute towards virulence of enterococci include 
the extent of GIT colonization, adherence to extracellular matrix proteins and the ability 
to adhere to the urinary tract or oral epithelial cells (Fisher & Phillips, 2009). The most 
studied enterococcal virulence factors include cytolysins, hydrolytic enzymes, 
aggregation substances, plasmid-encoded pheromones, cell-wall carbohydrate and 
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capsular polysaccharide, extracellular surface proteins and adhesins implicated in biofilm 
formation (Giraffa, 2014). Antibiotic resistance determinants may be categorised as a 
subtype of virulence factors owing to their ability to enhance bacterial persistence or 
chronic disease within the host (Emaneini et al., 2016).  
 
Secreted factors 
A variety of proteins produced by enterococci have been implicated in their virulence. A 
proportion of E. faecalis strains produce cytolysin, a toxin that can lyse several types of 
eukaryotic cells including immune cells and red blood cells (Cox et al., 2005). Cytolysin, 
produced by Enterococcus spp., is a bacteriocin that is active against the majority of 
Gram-positive bacteria and also falls under the class of antibiotic peptides (Van Tyne et 
al., 2013; Willey & van der Donk, 2007). Cytolysin production is encoded by an operon 
that may be located on the chromosome within a pathogenicity island, or on a pheromone-
responsive plasmid (Shankar et al., 2002; Ike et al., 1990). This operon consists of six 
genes involved in cytolysin biosynthesis and two encoding regulatory genes. Cytolysin 
comprises of a large and small oligopeptide subunit, encoded by cylLL and cylLS 
respectively, which undergo extensive post-translational modification to form active 
toxin subunits (Van Tyne et al., 2013). In the presence of target cells, these subunits 
interact to produce a pore in the target cell membrane, where the CylLL subunit has a 
higher binding affinity to the cell membrane leading to an accumulation of free CylLS 
which in turn triggers quorum sensing auto-induction leading to up-regulation of the 
cytolysin operon (Coburn et al., 2004). The CylM protein is responsible for dehydration 
of the subunits which is thought to be the initial post-translational modification process 
(Gilmore et al., 1994). Following this modification by CylM, the subunits are then 
secreted and trimmed by CylB followed by further processing by CylA serine protease 
which generates the active toxin (Gilmore et al., 1990; Segarra et al., 1991). 
 
The protease gelatinase (GelE) is responsible for degrading host tissue and altering the 
host immune system. It also plays a role in eliminating misfolded proteins and activates 
autolysin (Waters et al., 2003). The absence of GelE results in a significant decrease in 
biofilm formation, translocation across intestinal cells and reduced virulence in 
endocarditis (Thurlow et al., 2010; Arias & Murray, 2012). Elucidation of gelE has 
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revealed that it is activated by a quorum-sensing system in E. faecalis that is encoded 
within the fsr locus, which is comprised of three genes: fsrA, fsrB and fsrC (Qin et al., 
2000; Hancock & Perego, 2004). Expression of gelE is controlled by FsrB, a 
transmembrane protein that is ultimately regulated by the fsr locus. The absence of GelE 
results in a significant decrease in biofilm formation, translocation across intestinal cells 
and reduced virulence in endocarditis (Thurlow et al., 2010; Arias & Murray, 2012). Both 
GelE and Cyl are often recovered equally from isolates in patients with clinical infections 
and stools of healthy individuals. This demonstrates that potential enterococcal virulence 
determinants may also be harboured by strains colonizing the gastrointestinal tract of 
healthy individuals (Solheim et al., 2009). The GelE protease is also capable of increasing 
the intestinal permeability of the enteric epithelium, ultimately leading to intestinal 
inflammation (Maharshak et al., 2015). Zou et al. (2011) investigated the occurrence of 
erythromycin resistance and virulence genes in E. faecalis from pigs in China.  Statistical 
analysis led the authors to draw a significant correlation between the presence of gelE 
and the erythromycin resistance gene, ermB, in enterococcal isolates from swine livestock 
(Zou et al., 2011). This study suggested that enterococci from pigs may serve as potential 
reservoirs of resistance and virulence genes.  
 
Cell surface determinants 
Aggregation substance proteins (AS proteins), commonly found in E. faecalis, appear to 
play a significant role in contributing to the spread of antibiotic resistance genes in 
addition to enhanced pathogenesis. Genes encoding AS proteins are located on 
pheromone-responsive plasmids such as pAD1, pPD1 and pCF10, that also carry 
antibiotic resistance genes (Waters & Dunny, 2001). These proteins promote clumping 
of E. faecalis cells and facilitate the transfer of plasmids in liquid media (Arias & Murray, 
2012). Other cell surface proteins include endocarditis and biofilm-associated pili (Ebp), 
which are common among E. faecalis with significance in biofilm formation and 
pathogenesis in endocarditis models (Gao et al., 2010; Heikens et al., 2011). E. faecium 
often carries four or more putative pilus loci, two of which are known to produce pili and 
one which shows homology to the E. faecalis Ebp loci (Hendrickx et al., 2009; Sillanpää 
et al., 2010; Sillanpaa et al., 2008). It has been shown that Ebp and AS may be 
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systematically co-expressed to enhance densely packed biofilm formation (Afonina et al., 
2018). 
 
Microbial surface components recognising adhesive matrix molecules (MSCRAMMs) 
play a vital role in the initial stages of enterococcal infection by potentially binding 
components of the host extracellular matrix. The best-described adhesins are the collagen 
adhesins, Ace and Acm found in E. faecalis and E. faecium respectively. Like AS and 
Ebp proteins, these adhesins are anchored in the cell wall and contain LPxTG-like motifs. 
LPxTG-type surface proteins contain a LPxTG-like motif which becomes enzymatically 
cleaved and immobilizes the surface protein to the cell-wall peptidoglycan (Hendrickx et 
al., 2009). The folding patterns of Ace and Acm are similar to immunoglobulins and have 
a striking similarity to the S. aureus collagen adhesion (Cna) (Hendrickx et al., 2009). 
The Ace collagen and laminin adhesion is activated in the presence of collagen or serum 
and acts by “embracing” collagen molecule after docking (Nallapareddy & Murray, 
2006). Part of the cell wall-associated proteins from the WxL family is enterococcal 
leucine-rich-repeat-containing protein (ElrA) that is thought to be involved in virulence. 
Brinster et al. (2007) characterised the ElrA protein and noted that in a mouse peritonitis 
model, the disruption of the elrA gene in E. faecalis showed decreased virulence potential 
through impaired ability to infect macrophages.  
 
Other cell surface determinants include polysaccharides which are integral components 
of the cell surface of Gram-positive microorganisms and enable pathogenesis and evasion 
of phagocytosis (Arias & Murray, 2012). Some strains of E. faecalis contain capsular 
polysaccharide locus (cps) consisting of 8-9 genes. Enterococcal polysaccharide antigen 
(Epa) is a cell wall antigen that is often recovered from sera of patients with E. faecalis 
infections (Xu et al., 1997). The biosynthesis of this antigen is encoded by the epa locus.  
The disruption of the genes within this locus results in impaired biofilm formation, 
increased susceptibility to neutrophil-mediated cell death, and attenuation in peritonitis 





Sex pheromones which are generally chromosomally-encoded include cpd, cob, ccf and 
cad, are a strategy used by enterococci to accumulate plasmids (Clewell et al., 2002). A 
single enterococcal strain may secrete several different pheromones. Pheromone 
production by a recipient cell promotes the conjugative transfer of plasmids between the 
donor and recipient cells (Chandler & Dunny, 2004). Sex pheromones appear to be a 
significant contributing factor for enterococcal virulence while also participating in the 
dissemination of antibiotic resistance. The ccf gene has been implicated in activating 
conjugation of the pCF10 plasmid, which spreads tetracycline resistance genes (Akhtar 
et al., 2009). 
 
Other virulence factors 
Large transferable plasmids that are non-pheromone-responsive are commonly associated 
with clinical strains of E. faecium and contribute to virulence (Arias et al., 2009; Panesso 
et al., 2010). It has been shown that the transfer of a mega-plasmid from a clinical strain 
of E. faecium to a commensal strain, increased the virulence of the commensal strain in a 
mouse peritonitis model (Arias et al., 2009). Although the exact roles of genes harboured 
on these plasmids are not well defined, there is an indication that multiple genes in 
conjunction with each other offer increased virulence potential (Panesso et al., 2011). 
Some stress response proteins influence virulence, such as Gls24 which aids in resistance 
of E. faecalis to bile salts. E. faecalis also produces three types of peroxidase that 
neutralise reactive oxygen species, which act as mediators of bacterial death through 
phagocytosis. These include NADH peroxidase (Npr), Ahp (an alkyl hydroxyperoxide 
reductase) and a thiol peroxidase (Tpx) (La Carbona et al., 2007). Tpx offers the most 
effective protection against phagocytosis (La Carbona et al., 2007). 
 
1.2.10 Mobile genetic elements 
While identification of antibiotic resistance and virulence genes provides valuable insight 
into the mechanisms of resistance and virulence, it is equally important to understand 
their association with mobile genetic elements to predict the risk of acquisition and 
dissemination of these genes. There is little doubt that genetic exchange has enabled the 
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rise of Enterococcus as a nosocomial pathogen. Bacterial mobile genetic elements can be 
categorised as bacteriophages, plasmids, transposons, integrons and elements within 
elements (Stokes & Gillings, 2011). These elements play a significant role in the plasticity 
of enterococcal genomes through interactions with similar genomic elements and 
facilitate chromosomal and plasmid DNA rearrangements (Manson et al., 2010a). The 
genomes of E. faecalis and E. faecium may contain as much as 25% and 38% of foreign 
DNA or potential mobile genetic elements, respectively (Paulsen et al., 2003; Lam et al., 
2012). However, not all mobile genetic elements that are obtained by bacteria can be 
expressed; genes from Gram-positive bacteria can be transferred to Gram-negative 
bacteria, but the converse is not possible due to limitations in heterologous gene 
expression (Courvalin, 2008). Insertion sequences, on the other hand, are short portions 
of DNA encoding their transposition and can alter gene expression by altering their level 
of transcription (Depardieu et al., 2007). The mobility of these sequences can occur at 
random, making the emergence of resistance through gene activation challenging to 
predict (Courvalin, 2008). Resistance genes frequently share residence on the same 
genetic element as virulence factors which provide the bacterial host with an enhanced, 
multidrug-resistant phenotype (McCarthy & Lindsay, 2012).  
 
Plasmids 
A plasmid can be described as extrachromosomal DNA capable of autonomous 
replication that can be maintained in consecutive bacterial generations. Plasmids may be 
grouped as “narrow” or “broad host range” depending on host initiation factors or if all 
essential proteins are encoded on the plasmid (Jain & Srivastava, 2013). While clinical 
strains of enterococci possess an array of plasmids, the most notable are the pheromone-
responsive plasmids and the broad host range plasmids (Kristich et al., 2014).  
 
The best characterised pheromone-responsive plasmids include pAD1 and pCF10 
(Christie et al., 1987; Ehrenfeld & Clewell, 1987). These types of plasmids encode a 
response to sex pheromones (extracellular peptides) which are produced by potential 
recipient bacterial cell, thereby initiating conjugation. Chromosomally encoded peptide 
pheromones will specifically induce their cognitive pheromone-responsive plasmids: 
cCf10 induces pCF10 while cAD1 induces pAD1 (Dunny & Berntsson, 2016). The donor 
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cell (harbouring the pheromone-responsive plasmid) produces cell aggregation 
substances (AS) on the cell surface which facilitates cell-cell contact for conjugation and 
DNA transfer (Kozlowicz et al., 2006; Wardal et al., 2010; Yagi et al., 1983). Pheromone-
responsive plasmids are more commonly associated with E. faecalis as opposed to E. 
faecium (Gilmore et al., 2013). Such plasmids often harbour both virulence and antibiotic 
resistance determinants (Manson et al., 2010b).  
 
The pBRG1 pheromone-responsive plasmid which harbours the vanA operon has been 
shown to be transferrable from E. faecium LS10 to E. faecalis laboratory strains and is 
responsive to cCF10 pheromones (Magi et al., 2003). Vancomycin resistance associated 
with pheromone-responsive plasmids encoding the vanB operon has also been described 
in E. faecalis (Zheng et al., 2009). Two pheromone-responsive plasmids, pMG200 and 
pMG201, associated with the VanB-type determinants were described in E. faecalis 
NKH15. The pGM200 plasmid was shown to encode vancomycin resistance, bacteriocin 
production and response to pheromone cCF10. On the other hand, pMG201 encoded 
resistance to erythromycin, production of cytolysin virulence factors and response to 
pheromone cAD1 (Zheng et al., 2009). Sequencing of pMG200 revealed that a 
conjugative transposon, Tn1549-like element, contained the vanB-type determinant. It 
also revealed that this pheromone-responsive plasmid encoded a homologue to the 
negative regulatory gene of the pCF10 plasmid and a homologue of the positive 
regulatory gene of the pAD1 plasmid (Zheng et al., 2009). This indicates that the diversity 
of genetic arrangement of such housekeeping genes could be a consequence of genetic 
recombination between different pheromone-responsive or non-pheromone-responsive 
plasmids (Zheng et al., 2009). 
 
The “broad host range plasmids”, also known as incompatibility (Inc18) plasmids, are 
another class of enterococcal plasmids responsible for dissemination of antimicrobial 
resistance genes. Two plasmids of the Inc18 group have been well characterised in 
Streptococcus and Enterococcus spp.; pIP501 and pAMβ1. These plasmids encode 
multiple antimicrobial resistance genes against macrolides, lincosamides and 
streptogramin which can be transferred to other bacterial species (Zhu et al., 2010). The 
frequency of transfer of the Inc18 group of plasmids is significantly lower than that of 
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pheromone-responsive plasmids (Kristich et al., 2014). These plasmids employ a toxin-
antitoxin post-segregational killing system to ensure the maintenance of the plasmid even 
in the absence of selective pressure (Hayes, 2003). 
 
1.2.11 Role of plasmids in the dissemination of antibiotic resistance 
Plasmids encoding antibiotic resistance determinants may persist in isolates despite lack 
of selective pressure. This has been demonstrated in enterococcal isolates from Danish 
poultry where the use of avoparcin has been banned since the mid-1990s. Although there 
has since been a decline in VRE in Danish poultry as indicated in the DANMAP 2008 
and 2010 reports (DANMAP, 2008, 2011), a recent study has reported the persistence of 
vancomycin-resistant E. faecium (Leinweber et al., 2018). Leinweber et al. (2018) 
revealed that these isolates contained a non-conjugative pVEF4-like plasmid, designated 
pVEF4_A, harbouring the transferable vanA gene cluster within transposon Tn1546. 
Persistence of such plasmids in the absence of selective pressure is believed to be as a 
result of the three-component ω/ε/ζ toxin-antitoxin system or the prgOPN gene cluster 
which is thought to stabilise plasmids through toxin-antitoxin-independent mechanisms 
(Sletvold et al., 2008; Li et al., 2011). Further work revealed that the presence of the 
conjugation-encoding plasmid pHLSA might play a significant role in the transfer of 
resistance-conferring plasmid, pVEF4_A.  Antibiotic resistance determinants are often 
clustered on plasmids which can lead to co-selection of resistance. Tremblay et al. (2011) 
reported on the antibiotic resistance determinants and plasmid co-localization of 
tetracycline and macrolide genes in E. faecium and E. faecalis in poultry flocks in Canada.  
This study was the first to report co-localization of ermB and tetO genes on a low 
molecular weight plasmid harboured by MDR E. faecalis of poultry origin in Canada. 
Furthermore, conjugation experiments proved that this plasmid could confer antibiotic 
resistance to other bacteria. This study also noted tetracycline resistance even though 
these drugs are not often used in poultry operations in Canada, suggesting that the use of 
MLSB antibiotics could enable maintenance of tetracycline resistance through co-





The most largely studied enterococcal transposons include those that encode 
antimicrobial resistance determinants, virulence factors and ease of transfer. Enterococcal 
transposons can be grouped under three main categories: composite transposons, Tn3-
family transposons and conjugative transposons (Kristich et al., 2014). Composite 
transposons have been commonly associated with high-level gentamicin resistance and 
vanB1-type resistance (Hegstad et al., 2010). Their mobility is encoded by insertion 
sequences (IS elements). These IS elements, encoding enzymes required for their 
transposition, are identical sequences that may be directly orientated or inverted repeats 
that flank either side of composite transposons. The Tn5281 transposon confers resistance 
to all aminoglycosides except for streptomycin. Resistance can be attributed to a 
bifunctional aminoglycoside-altering gene, acc-6’/aph-2’’, which is unique to Tn5281-
like elements (Ubukata et al., 1984; Courvalin et al., 1980; Hodel-Christian & Murray, 
1991). The Tn5281 element encoded on E. faecalis pBEM10 plasmid is flanked by two 
copies of IS256-like sequences at one terminus. This transposon is almost identical to S. 
aureus Tn4001 and S. epidermidis Tn4031 except that both these composite transposons 
are flanked by single copies of IS256 elements at each terminus (Hodel-Christian & 
Murray, 1991).  
 
The Tn5385 composite transposon, identified in E. faecalis, is an example of a mobile 
element able to confer multi-resistance through the incorporation of other putative 
transposons within the larger element. Two of the known transposons include Tn4001 
which confers resistance to gentamycin and Tn5384 which is encoded between the IS256 
terminus of Tn4001 and another IS256 located 26kb away (Rice et al., 2009). The 
determinants for resistance to gentamycin, macrolides and mercury is encoded on the 
region between these two IS elements. An additional element Tn5381, which is a Tn916-
like conjugative element, is also encoded on the larger Tn5385 element and appears to be 
identical to Tn552; a staphylococcal transposon mediating β-lactamase resistance (Rice 
et al., 2007).  
 
The most notable Tn3-family of transposons is the Tn1546 element which encodes the 
vanA-type operon (Arthur et al., 1993). Similar to the expression mechanisms of related 
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enterococcal Tn3-family of transposons, the Tn1546 expression is induced upon exposure 
to glycopeptides (Arthur et al., 1993). The vanA operon is almost always found in 
association with the Tn1546 element. However, more variants are being observed in 
clinical isolates and are thought to have emerged as a result of the insertion of IS elements 
within transposons. Tn1546 may be encoded chromosomally or on transferable plasmids. 
Transmission of vancomycin resistance to S. aureus has been implicated solely with 
Tn1546-like elements in association with Inc18-type plasmids (Zhu et al., 2010).  
 
Antibiotics can act as initiators of resistance genes movement. Some transposons, such 
as Tn3, are mobilised in the presence of the antibiotic to which they convey resistance. 
For example, the enterococcal transposon Tn917 described initially in E. faecalis DS16, 
confers resistance to MLSB and related antibiotics. Upon exposure to erythromycin, this 
Tn917 element shows enhanced mobility (Courvalin, 2008). The determinant for the 
MLS resistance is encoded by the erm gene which translates into a methylase which alters 
23S rRNA (Shaw & Clewell, 1985). According to the sequence analysis carried out by 
Perkins et al., (1984), and Horinouchi et al. (1981), there appears to be almost perfect 
sequence homology between a region of Tn917 and the erm gene located on pAM77. It 
is hypothesised that the homology is a result of abortive transposition or recombination 
with a Tn917-like element. On the other hand, Tn917 may have evolved from a pAM77 
element incorporating transposition functions (Shaw & Clewell, 1985; Perkins & 
Youngman, 1984; Horinouchi & Weisblum, 1981). The Tn917 element displays 
increased transposition in cells exposed to sub-inhibitory concentrations of erythromycin 
(Courvalin, 2008; Shaw & Clewell, 1985; Tomich et al., 1979). Experiments carried out 
by Shaw et al. (1985) using mRNA analysis revealed that E. faecalis DS16 exposed to 
erythromycin produced increased Tn917-specific transcripts compared to those that were 
not exposed to the drug. This could be attributed to the increased induction of resistance. 
While Tn917 also shows significant homology with the S. aureus Tn551 transposon, the 
MLS resistance of the latter element is expressed constitutively (Perkins & Youngman, 
1984; Shaw & Clewell, 1985).  
 
Conjugative transposons mobilize through excision from their point of origin and insert 
into their target sites without replication (Celli & Trieu-Cuot, 1998). These elements 
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display the remarkable ability to transfer between enterococcal chromosomes and show 
a broad host range (Carias et al., 1998). Tn916 was the first conjugative transposon 
described, encoding the tetM gene conferring tetracycline and minocycline resistance. 
Tn916-like elements are the most common vectors for the spread of tetM genes amongst 
Gram-positive bacteria with the ability to also disseminate to Gram-negative bacteria 
(Swartley et al., 1993). More recently, Scornec et al. (2017) reported that several 
antibiotics could activate the transfer of Tn916 despite the lack of cognate antibiotic 
resistance genes located on the transposon. These included spectinomycin of the 
aminoglycosides, tetracycline and doxycycline of the tetracyclines and lincomycin and 
clindamycin of the lincosamides. It is of concern that activation of mobility of Tn916 can 
be induced by a broad range of antibiotics since this implies that the dissemination of 
resistance determinants is not entirely dependent on the cognate antibiotics to which this 
element encodes resistance (Scornec et al., 2017). 
 
An expansion of the Tn916-family of transposons is the Tn5382 element which harbours 
the vanB operon. (Carias et al., 1998). Sequencing data of various enterococcal strains 
suggest that Tn5382 and closely related elements are the fundamental structures that 
harbour the vanB operon (Lu et al., 2005; Bjørkeng et al., 2011). A study carried out by 
Carias et al. (1998) provided a possible explanation for the frequent association of 
vancomycin and high-level ampicillin resistance observed in clinical strains of E. 
faecium. This study reported the transfer of vancomycin, ampicillin and tetracycline 
resistance from E. faecium C68 to E. faecium GE-1 which proved to be associated with 
the uptake of a region of DNA harbouring the Tn5382 element and pbp5 gene. In 2010 
Jasni et al. conducted the first study that demonstrated the reciprocal genetic exchange of 
Tn5397, encoding tetracycline resistance, between E. faecalis and Clostridium difficile. 
Although the laboratory conditions provided the ideal situation of genetic exchange 
between the organisms, as opposed to the natural environment, these findings emphasize 
the importance of continual ABR monitoring.  
 
In an attempt to characterise erythromycin and tetracycline-resistant E. faecalis in retail 
chicken meat in China, Kim et al. (2018) reported that a significant proportion of isolates 
showed simultaneous resistance to both erythromycin and tetracycline. Furthermore, 
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most isolates simultaneously harboured the corresponding resistance genes; ermB 
(erythromycin resistance), tetM and/or tetL (tetracycline resistance). Investigating for the 
presence of transposons revealed that 5.8% of isolates were positive for the Tn916/1545 
element. Despite the low occurrence noted in this study, such findings should receive 
more attention for future surveillance studies regarding the risk associated with horizontal 
gene transfer of resistance genes in enterococci (Kim et al., 2018). 
  
1.2.12 CRISPR-Cas and its role in the acquisition of mobile genetic elements 
Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR) is a system that 
enables bacteria to evade infection by bacteriophages and foreign mobile genetic 
elements. CRISPR is characterised by the presence of short palindromic repeats separated 
by spacer sequences. These DNA arrays are often flanked by CRISPR-associated genes 
such as cas (Barrangou & Marraffini, 2014). The CRISPR system works in the following 
way: when a foreign mobile genetic element is introduced into a cell, a segment of this 
foreign DNA may be incorporated into the CRISPR array, serving as a genetic memory 
bank of encountered foreign DNA. There are three main types of CRISPR-Cas systems 
(type I, II and III), each with its specific cas gene (Makarova et al., 2011). The Type II 
systems associated with cas9, which include CRISPR1-Cas and CRISPR3-Cas, are often 
encountered in E. faecalis (Palmer & Gilmore, 2010). A third CRISPR system has been 
observed in almost all sequenced E. faecalis genomes and is called CRISPR2,  an orphan 
locus devoid of cas genes (Palmer & Gilmore, 2010; Hullahalli et al., 2015). The genomes 
of MDR bacteria/pathogens are larger than those of commensals due to the acquisition 
and maintenance of mobile genetic elements. An investigation conducted by Mikalsen et 
al. (2015) using DNA microarrays to detect CRISPR-Cas elements in clinically relevant 
lineages of E. faecalis and E. faecium revealed that there was a complete lack of these 
elements in all E. faecium isolates tested. In contrast, the majority of E. faecalis ST40 
strains showed evidence of CRISPR-Cas sequences, hence, a putative functional system. 
These strains also harboured several acquired antibiotic resistance genes contrary to the 
reports made by Palmer and Gilmore, (2010) that MDR enterococci were devoid of 
CRISPR-Cas elements (Mikalsen et al., 2015). Furthermore, it has recently been shown 
that some E. faecalis strains have the potential to attenuate their existing CRISPR systems 
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which ultimately aids in the uptake of beneficial mobile genetic elements (Hullahalli et 
al., 2018). 
1.2.13 Prevalence of antibiotic-resistant enterococci in food animals and the 
implications for human health 
Although enterococci are natural commensals in animals, ABR strains can be potentially 
transmitted to humans via direct contact with animals or indirect contact with 
contaminated meat products. While zoonotic transmission of ABR enterococci mainly 
affects farm workers, veterinarians or slaughterhouse workers, the population as a whole 
can be affected through contact or consumption of contaminated meat (Marshall & Levy, 
2011). Although the risk of zoonotic disease is rare, more attention should be drawn to 
the fact that ABR strains may serve as a reservoir of resistance determinants for more 
pathogenic microorganisms of the GIT. It is known that antibiotic resistance determinants 
have the potential to be transferred to microorganisms of the same or different 
strain/species. The use of critically important, clinical-related antibiotics in food animals 
has implications for human health since this can create a selective environment for the 
emergence of new MDR pathogenic strains. Noble et al. (1992) reported that genes 
conferring vancomycin-resistance have the potential to be transmitted to other Gram-
positive pathogens such as S. aureus which raises an alarm in terms of the health concerns 
for vancomycin and methicillin-resistant S. aureus.  
 
Abat et al. (2016) investigated the unusual increase in E. faecalis community-acquired 
urinary tract infections across various medical institutes within the Provence-Alpes-Côte 
d’Azur region of France. It was speculated that this outbreak was linked to zoonotic 
transmission, as a result of Enterococcus-contaminated poultry meat. This study drew 
parallels with an investigation carried out in Vietnam which linked poultry as a possible 
reservoir for E. faecalis-associated urinary tract infections in humans where identical or 
closely-related strains types were isolated from chickens and infected patients (Poulsen 
et al., 2012). 
 
In a Canadian study carried out by Aslam et al. (2012), characterization of ABR and 
virulence genotypes of Enterococcus spp. was carried out using samples of retail meat 
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(beef, chicken, pork and turkey). MDR E. faecalis was predominant in poultry meat as 
opposed to beef and pork. The lack of VRE isolation in this study was attributed to the 
fact that avoparcin was never approved for use in animal feed in Canada (Aslam et al., 
2012). This study emphasised the importance of E. faecalis as a reservoir of resistance 
and virulence genes and their potential to be transmitted to humans by exposure to 
contaminated, undercooked meat. It also suggested that clinically relevant resistance 
genes were more likely to be recovered from retail poultry meat. Therefore, poultry meat 
potentially plays an important role in the spread of resistance genes to consumers through 
handling meat or ingestion of undercooked meat contaminated with enterococci (Aslam 
et al., 2012). 
 
1.2.14 Prevalence of ABR and virulence enterococci in South Africa 
In a study carried out by Iweriebor et al. (2015), faecal samples from two piggery farms 
located in the Eastern Cape, South Africa, were collected to determine the antibiotic 
resistance and virulence profiles of Enterococcus species. The predominant species was 
E. faecium (37.5%). All enterococcal isolates were reported to be resistant to most of the 
antibiotics tested against them including vancomycin. The isolates also showed resistance 
to at least two different classes of antibiotics, with approximately 93.8% of isolates 
displaying resistance to five or more antibiotics. Isolates showed high levels of resistance 
to antibiotics commonly used in the two farms: Penicillin (91%), erythromycin (98.72%) 
which is often selected for by the use of tylosin, and ciprofloxacin (77.5%). In 
correspondence to the antibiotic-resistance phenotypes observed, the following genes 
were identified: strA (streptomycin resistance), ermB (erythromycin resistance), vanB, 
vanC1 and vanc2/3 (vancomycin resistance). The high prevalence of MDR VRE raises 
serious concerns for human health since vancomycin is among the last resort antibiotics 
against Gram-positive bacteria (Schmidt, 2011). The same authors reported a high 
prevalence of MDR enterococci in dairy cattle within the same vicinity of the piggery 
farms (Iweriebor et al., 2016). Once again, the predominant species proved to be E. 
faecium (52.94%). All isolates were reported to be resistant to vancomycin followed by 
a high aminoglycoside resistance (neomycin [91%] and streptomycin [94%] as well as 
macrolide resistance (erythromycin [99%)]. The authors further suggested that tylosin use 
in dairy cattle production may have led to the high levels of erythromycin resistance due 
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to the similarity of the target site of these drugs.  Pillay et al. (2018), reported that a 
predominance of E. faecalis (80%) followed by E. faecium (10%) in chicken cloacal 
samples originating from a poultry farm within KwaZulu-Natal. When compared to 
enterococcal isolates from companion animals and livestock, it was revealed that the 
highest incidence of virulence genes, >80% gelE and >80% ccf, was detected in 
enterococci of poultry origin. This is of interest since pathogenicity is not solely 
determined by antibiotic resistance but in conjunction to virulence factors. 
 
1.2.15 Justification for study 
To date, there have been limited studies carried out in South Africa on the prevalence and 
antibiotic resistance profiles of Enterococcus spp. in poultry. Many studies conducted 
worldwide focus on the molecular epidemiology of enterococci in poultry production, 
however, no data is available in South Africa regarding the relationships between 
enterococci isolates along the farm to fork continuum. This is an important route of 
investigation to determine the molecular epidemiology of antibiotic-resistant 
Enterococcus spp. and their possible routes of poultry meat contamination from 
production and slaughter through to retail chicken meat. There is thus a need to quantify 
the burden of antibiotic-resistant Enterococcus spp. in the poultry industry across the farm 
to fork continuum in order to inform evidence-based measures for its containment. 
1.3 Aim 
The aim of this study was to delineate the molecular epidemiology of antibiotic-resistant 
Enterococcus spp., from farm to fork, in chickens from an intensive farming system in 
uMgungundlovu District, KwaZulu-Natal. 
 
1.4 Objectives 
• To isolate Enterococcus spp. along the farm to food-production chain continuum from 
an intensice poultry farming system in the uMgungundlovu district, KwaZulu-Natal.  
• To determine the antibiotic resistance profiles of Enterococcus spp. isolated from an 
intensive poultry farming system.  
• To identify the genes responsible for resistance.  
• To identify virulence genes harboured by the isolated enterococci. 
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• To determine clonal similarities using repetitive element palindromic PCR (REP-
PCR). 
 
1.5 Study outline  
This study aimed to investigate the molecular epidemiology of antibiotic-resistant 
Enterococcus spp. from farm to food-production chain, in an intensive poultry production 
farm in the uMgungundlovu District, KwaZulu-Natal. The research is presented in three 
chapters as follows: 
Chapter 1 provides the background, literature review, rationale for the study as well as 
the aims and objectives. 
Chapter 2 provides information about the investigations undertaken and the findings 
presented in the form of a manuscript prepared for Science of the Total Environment  
Chapter 3 presents the conclusions, limitations and recommendations for this study. 
 
1.6 Summary of methodology 
Ethical considerations 
Ethical approval was obtained from the Animal Research Ethics Committee (Reference: 
AREC 073/016PD) and the Biomedical Research Ethics Committee (Reference: 
BCA444/16) of the University of KwaZulu-Natal (Appendices 1 and 2). The study was 
further placed on record with the South African National Department of Agriculture, 
Forestry and Fisheries (Reference: 12/11/1/5 (879)). Human samples were obtained from 
participants 18 years or older upon explicit, voluntary, verbal informed consent as per the 
participant information leaflet (Appendix 8). All information disclosed by the farm was 
treated as confidential as per the memorandum of understanding (MOU) between the 
Antimicrobial Research Unit (ARU) and the farm. 
General methodology 
This study describes the molecular epidemiology of antibiotic-resistant Enterococcus 
spp. from farm to food-production chain in intensive poultry production in KwaZulu-
Natal, South Africa. Samples along the poultry farm to food-production chain continuum 
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(litter and faeces, transport, holding, abattoir and retail meat) were evaluated for the 
presence of Enterococcus spp. Molecular confirmation by PCR, targetting the genus- (tuf) 
and species-specific (sodA) genes was undertaken. Susceptibility profiles were assessed 
by Kirby-Bauer disk diffusion using the WHO-AGISAR recommended panel of 
antibiotics for Enterococcus spp. Antibiotic resistance and virulence genes were detected 
using real-time PCR. Genetic relatedness between isolates across the continuum was 
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Background: The poultry industry is among the main suppliers of meat protein worldwide. 
Extensive antibiotic use in intensively-farmed poultry exerts selection pressure for the 
emergence of multidrug-resistant pathogens. The aim of this study was to determine the 
antibiotic resistance and virulence profiles of Enterococcus spp. along the farm to food-
production chain continuum in an intensive poultry system in the uMgungundlovu District in 
Kwazulu-Natal, South Africa. Methods: A total of 187 samples along the poultry farm to food-
production chain continuum (litter, faeces, transport, holding, abattoir and retail meat) were 
evaluated for the presence of Enterococcus spp. using selective media, biochemical tests, API 
20 Strep kits followed by molecular confirmation by PCR, targetting the genus- (tuf) and 
species-specific (sodA) genes. Resistance profiles were assessed by the Kirby-Bauer disk 
diffusion method against the WHO-AGISAR recommended panel of antibiotics for 
Enterococcus spp. using CLSI guidelines. Real-time PCR was used to detect antibiotic 
resistance and virulence genes. Clonal similarities and differences between isolates across the 
continuum were evaluated by REP-PCR. Results: One hundred and thirty-four (134) isolates 
were recovered across the continuum with a prevalence of 72%. Molecular screening 
confirmed 36% of the isolates as E. faecalis, 31% as E. faecium, 2% as E. gallinarum and 31% 
as other Enterococcus spp. Resistance to tetracycline (80%), erythromycin (71%), 
nitrofurantoin (17%), ampicillin (15%), streptomycin (15%), chloramphenicol (11%), 
ciprofloxacin (5%), tigecycline (4%), gentamicin (4%), teicoplanin (3%) was observed among 
Enterococcus spp., but no vancomycin resistance (0%). E. faecium displayed 24% resistance, 
and 21% were of intermediate susceptibility to quinupristin-dalfopristin. Twenty-one (21%) of 
E. faecalis and 100% of E. gallinarum, showed intermediate susceptibility to vancomycin. 
Forty-three percent of E. faecium were multidrug-resistant (MDR) (resistant to one or more 
antibiotics in three or more antibiotic classes). The most frequently observed antibiotic 
resistance genes, associated with phenotypic resistance, were tetM (76%) and ermB (67%) 
while a small percentage was noted for aph(3’)-IIIa (12%) and vanC1 (1%). Virulence genes 
efaAFs (100%), cpd (96%) and gelE (81%) were more frequently detected in E. faecalis. Cell 
wall adhesin (efaAFm) was more common in E. faecium (100%) and other Enterococcus spp. 
(71%). Clonality evaluated by REP-PCR revealed that isolates along the continuum are highly 
diverse with major REP-types often consisting of isolates from the same sampling point. 
Conclusion: This study highlights MDR Enterococcus in the poultry food production chain 
with isolates harbouring both resistance and virulence genes which can serve as a reservoir for 
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the potential transfer of these genes from poultry to humans through the farm to food-
production chain continuum. The findings underscore the need for routine antibiotic resistance 
surveillance in food animals. 
Keywords: Antibiotic-resistance; Enterococcus spp.; multidrug resistance; farm to food-

























Antibiotic resistance (ABR) is a global concern resulting in increased mortality rates and 
healthcare costs. While microorganisms are experts at adaptation, there is little doubt that 
human activity has influenced their evolution (Sun et al., 2012). Agricultural antibiotic 
consumption is a significant driving force for ABR. It is estimated that approximately 148 
mg/kg of antibiotics are used for farmed chickens globally (Van Boeckel et al., 2015). In South 
Africa, the poultry industry is among the leading suppliers of meat protein, with chicken being 
in high demand across all income groups (Greenberg et al., 2017; DAFF, 2017). Intensively-
farmed poultry increases the risk of dissemination of respiratory and intestinal bacteria 
(Greenberg et al., 2017) and antibiotics are thus generally used for prophylactic or 
metaphylactic treatment to minimise the risk of such outbreaks amongst these closely housed 
animals (Van Boeckel et al., 2015; Venter et al., 2017a). Antibiotics are administered to 
improve poultry health, growth performance and minimise the risk of enteric disease. However, 
the use of antibiotics as growth promoters has come under scrutiny with concern for the 
emergence of multidrug-resistant bacteria (MDR) (M’Sadeq et al., 2015) as antibiotic growth 
promoters (AGPs) are often used at sub-therapeutic concentrations within feed or water 
supplies for prolonged durations (Wielinga et al., 2014). The major issue of antibiotic use in 
poultry is not the residual drugs in the meat, but rather the potential of these antibiotics being 
a driving force in the emergence of MDR pathogens. AGPs have the potential to alter the 
microbiome of food-animals and contribute to the enhanced transfer of ABR within the animal 
and environmental microbiome (You & Silbergeld, 2014).  
 
Enterococcus spp. often serve as indicator bacteria for the surveillance of ABR in food-animals 
since they are naturally occurring in both humans and animals (WHO, 2017b). Additionally, 
these microorganisms can be used for monitoring ABR to antibiotics active against Gram-
positive bacteria (WHO, 2017b). While generally considered commensals, Enterococcus spp. 
have emerged among the leading causes of nosocomial infections (Sievert et al., 2013). The 
World Health Organization (WHO) has recently listed vancomycin-resistant enterococci 
(VRE) among the crucial resistant bacteria in the “global priority list of antibiotic-resistant 
bacteria for the research and development of new antibiotics” (WHO, 2017a). Among the 
genus, Enterococcus faecium and Enterococcus faecalis are the most prevalent nosocomial 
pathogens responsible for approximately 10-15% and 80-90% of infections, respectively 
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(Giraffa, 2014). Enterococcus gallinarum and Enterococcus casseliflavus are responsible for a 
minority of clinical infections (Monticelli et al., 2018). 
  
Enterococci have intrinsic and acquired resistance to an array of antibiotics. Invasive infections 
caused by these microorganisms are often treated with a combination of a β-lactam antibiotic 
and an aminoglycoside; alternatively, glycopeptides such as teicoplanin or vancomycin are 
used (Hammerum et al., 2010). Although vancomycin is among the last resort treatment options 
against Gram-positive pathogens, there has been an increase in VRE globally (Santajit & 
Indrawattana, 2016; Remschmidt et al., 2018). This is a major call for concern as VRE may 
serve as a reservoir of ABR determinants for more pathogenic Gram-positive microorganisms 
such as vancomycin-resistant  Staphylococcus aureus (VRSA) (Chang et al., 2003).  
 
The use of critically important, clinically relevant antibiotics in food animals has the potential 
to create a selective environment for MDR pathogenic strains. Additionally, despite rare 
zoonotic transmission of disease, it is important to note that resistant enterococcal strains may 
serve as a reservoir of resistance genes for more pathogenic bacteria in the gut (Bortolaia et al., 
2016). Enterococci may contaminate poultry meat at the slaughter (abattoir) and post-slaughter 
level (retail meat) through handling involving cross-contamination with poultry faecal matter 
(Bortolaia et al., 2016). While zoonotic transmission of ABR enterococci mainly affects farm 
workers, veterinarians or slaughterhouse workers, the population as a whole can be affected 
through contact or consumption of contaminated meat (Marshall & Levy, 2011).  
 
The success of pathogenic enterococci is not solely due to their ABR profiles, but also in 
conjunction with virulence determinants. Enterococcus spp. may host an array of virulence 
factors including aggregation substance (asa1), cytolysin (cylA), gelatinase (gelE), 
enterococcal surface proteins (esp), cell wall adhesins (efaA), among many others (Vidana et 
al., 2016; Eaton & Gasson, 2001). There is currently limited data on the molecular 
epidemiology of enterococci in poultry in South Africa. Furthermore, no studies have been 
conducted to investigate this along the farm to food-production chain continuum. There is, 
therefore, a need to ascertain the antibiotic resistance of Enterococcus spp. in poultry with the 
goal to encourage implementation of measures for its containment. This study delineated the 
molecular epidemiology of antibiotic-resistant patterns Enterococcus spp., from farm to food-






2.1 Ethical clearance 
This project forms part of a broader study for which ethical approval had been obtained from 
the Animal Research Ethics Committee (Reference: AREC 073/016PD) and the Biomedical 
Research Ethics Committee (Reference: BCA444/16) of the University of KwaZulu-Natal. The 
study was further placed on record with the South African National Department of Agriculture, 
Forestry and Fisheries (Reference: 12/11/1/5 (879)).  
 
2.2 Study population and sampling  
This study was conducted over seven weeks, between August and September 2017 at an 
intensive poultry production system in the uMgungundlovu District of KwaZulu-Natal, South 
Africa,  using the farm to food-production chain approach as recommended by the WHO-
AGISAR (WHO, 2017b) as follows:  
Growth period: Litter and faecal samples were collected from Cobb breed chickens weekly 
over five weeks (n=100). Block sampling was used to ensure representation of the entire flock 
within the poultry house where total litter (n=10) and total faecal (n=10) samples were pooled 
together weekly. Faeces and litter from the pooled samples (1 g each) were inoculated 
separately into 40 ml of tryptone soya broth (TSB) (Oxoid, Hampshire, England) and incubated 
at 37 °C for 2 h with shaking at 100 rpm. Following incubation, 1 ml of each culture was 
inoculated into 9 ml of TSB supplemented with 6.5% NaCl and incubated at 37 °C for 24 h 
with shaking at 100 rpm. During Week 2, human hand swabs and nasal swabs of farm 
employees (n=8, respectively) were pooled and processed as described.  Human samples were 
obtained from participants 18 years or older upon explicit, voluntary, verbal informed consent 
as per the participant information leaflet (Appendix 8) 
Transport and holding: Sterile swabs (n=10) of holding areas (transport crates) and the truck 
(n= 10) were used to randomly sample truck and crate surfaces that were exposed to the target 
flock. This was collected during transportation of the target flock to the slaughterhouse. Swab 
samples were pooled into 40 ml of TSB and processed as above.  
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Slaughter: Upon the sacrifice of the flock at the abattoir, 40 ml of carcass rinsate was collected 
in a sterile tube as water streamed down several carcasses, 4 ml was inoculated into 36 ml of 
TSB and processed as above.   
Post-slaughter: Caeca from 10 chickens were removed, and 1 g of caeca from each chicken 
was inoculated into 5 ml TSB, homogenised and pooled into a sterile tube to a final volume of 
50 ml. One millilitre of this homogenate was inoculated into 9 ml of TSB and processed as 
above. 
Retail meat: Neck, thigh and whole chicken carcass portions (n=10, respectively) were each 
rinsed in 10 ml of 0.9% sterile saline solution, which were then pooled together to give a final 
volume of ~ 100 ml for each portion. Four millilitres of each homogenate were inoculated into 
36 ml of TSB and processed as above.  
House rinsate: Prior to disinfection of the chicken housing, in preparation for introduction of 
the new flock, one millilitre of the flock house rinsate was collected from random points as the 
house was hosed down. One millilitre was inoculated into 9 ml of TSB and processed as above.   
All samples were transported in a cooler box at 6 °C and processed within 4 hours from the 
time of collection. 
 
2.3 Isolation and identification of Enterococcus 
2.3.1 Phenotypic Determination of Enterococcus 
All 24 h cultures were sub-cultured by spread plating 100 µl onto Bile Esculin Azide agar 
(Himedia, Mumbai, India). Plates were incubated for 24 h at 37 °C, and brown-grey colonies 
surrounded by black halos were considered presumptive enterococci. Identified colonies were 
further streaked onto Bile Aesculin agar (Lab M, Lancashire, UK), and incubated at 37 °C to 
obtain pure colonies. Presumptive colonies were then streaked onto 5% Sheep Blood agar 
(Oxoid, Hampshire, England) for characterisation of haemolysis, and Tryptone Soya Agar 
(TSA) (Oxoid, Hampshire, England) for further phenotypic characterisation. The biochemical 
characterisation of the isolates included catalase activities using 3% H2O2, oxidase strips 
(Sigma Aldrich, St. Louis, USA) and the Gram string test (Gregersen, 1978). Further 
confirmatory biochemical characterisation was performed using API 20 Strep kits (Biomerieux 
SA, Marcy I'Etoile, France). Isolates showing percentage identification >80% by API were 
further analysed for molecular confirmation. S. aureus American Type Culture Collection 
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(ATCC) 29213 and E. faecalis ATCC 29212 were used as controls. Presumptive enterococci 





2.3.2 Molecular confirmation of isolates 
Stock cultures were resuscitated on TSA plates incubated at 37 °C for 24 h. DNA was extracted 
using the heat lysis method as previously described (Englen & Kelley, 2000). A multiplex 
polymerase chain reaction (PCR) was performed to confirm isolates at the genus and species 
level. Genus-specific and species-specific primer used in all the reactions were as previously  
described  (Jackson et al., 2004; Ke et al., 1999) (Table 1). Two PCR reaction mixtures, both 
containing the Enterococcus genus-specific primers, were set up for different primer sets as 
follows: group 1: E. faecalis and E. faecium; group 2: E. gallinarum; group 3: E. casseliflavus.  
Each reaction was performed in a total volume of 15 µl consisting of 8 µl of DreamTaq Green 
PCR Master Mix (2X) (Thermo Scientific, Lithuania), 0.5 µl of each primer pair (final 
concentration of 10 µM of each primer, except for E. faecium and E. casseliflavus where 16 
µM of the species primer was used), 2.5 µl of template DNA and 1.5 µl of nuclease-free water. 
The following thermal cycling conditions used: initial denaturation at 95 °C for 4 min, 30 
cycles of denaturation at 95 °C for 30 s, amplification at 46.1 °C for 1 min, elongation at 72 °C 
for 1 min and a final extension at 72 °C for 7 min. All reactions were carried out in a T100 ™ 
thermal cycler (Bio-rad, South Africa). All reactions included a positive control (Table 1) and 
a “no template control (NTC)”. The PCR products were electrophoresed at 90 V on a 1.8% gel 
run in Tris-borate-EDTA (0.5X) containing 0.5 µg/ml ethidium bromide and visualized using 
the Gel Doc™ XR+ imaging system (Bio-rad, South Africa).   
Table 1: List of genus- and species-specific primers and control strains used in this study 
Control Strain  Primer Primer sequence 5’-3’  Product size 
(bp) 
Reference  




112 (Ke et al., 1999) 




360 (Jackson et al., 
2004) 



















*Field strains were provided by the National Health Laboratory Services (NHLS), South Africa 
93 
 
2.4 Antimicrobial susceptibility testing 
Susceptibility to different antibiotics was determined using the Kirby Bauer disk diffusion 
method, on Mueller Hinton agar (Oxoid, Basingstoke), according to the Clinical and 
Laboratory Standards Institute (CLSI, 2017) recommendations. The European Committee on 
Antimicrobial Susceptibility Testing (EUCAST, 2017) guidelines were used for those 
antibiotic breakpoints absent from the CLSI guidelines. The antibiotic panel selected for 
screening enterococcal isolates included those stipulated in the World Health Organization 
Advisory Group on Integrated Surveillance of Antimicrobial Resistance (WHO, 2017b). The 
following antibiotics were used: ampicillin (10 µg), vancomycin (30 µg), teicoplanin (30 µg), 
erythromycin (15 µg), tetracycline (30 µg), ciprofloxacin (5 µg), nitrofurantoin (300 µg), 
chloramphenicol (30 µg), linezolid (30 µg) and tigecycline (16 µg). The susceptibility profile 
of quinupristin-dalfopristin (15 µg) was only reported for E. faecium since it is only clinically 
relevant for this enterococcal species. All antibiotics were purchased from Oxoid, Basingstoke, 
United Kingdom. S. aureus ATCC 25923 was used as the control strain as recommended by 
CLSI guidelines. High-level aminoglycoside resistance was determined using gentamicin (120 
µg) and streptomycin (300 µg) discs on Mueller-Hinton agar with E. faecalis ATCC 29212 as 
the control strain. 
 
2.5 Detection of antibiotic resistance and virulence genes 
Real-Time PCR was used to detect antibiotic resistance and virulence genes using the primers 
listed in Table 2 and Table 3, respectively. The reactions were carried out in a total volume of 
10 µl made up of 5 µl of Luna® Universal qPCR master mix (New England Biolabs), 0.5 ul of 
each forward and reverse primer set (final concentration, 0.5 µM each), 3 µl of template DNA 
and 1 µl of nuclease-free water. The optimised cycling conditions were as follows: a hot-start 
activation at 98 °C for 50 s followed by 30 cycles of denaturation (95 °C for 50 s), annealing 
(55 °C for 1 min) and extension (72 °C for 1 min). A final extension was achieved at 72 °C for 
5 min. The melt-curve was subsequently achieved by a pre-melt step at 95 °C for 15 s followed 
by ramping the melting temperature from 60 °C to 95 °C at a ramp rate of 0.15 °C/s. All 
reactions were carried out in a QuantStudio 5 Real-Time PCR System (ThermoFisher 
Scientific, South Africa). Each PCR assay included a positive and a No Template Control 
(NTC). The positive control strains for each gene are listed in Table 2 and Table 3. The NTC 
was made up of the PCR mix with template DNA replaced by nuclease-free water.
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Table 2: List of antibiotic resistance genes primers.  
Gene Description Positive control Strains Primer sequence (5’-3’) Reference  
tetK Tetracycline 
resistance 
S. aureus clinical strain * F- TTAGGTGAAGGGTTAGGTCC 
R- GCAAACTCATTCCAGAAGCA 
(Aarestrup et al., 
2000a) 




E. faecalis ATCC 51299 F- CTATCTGATTGTTGAAGAAGGATT 
R- GTTTACTCTTGGTTTAGGATGAAA 




E. faecium ATCC 700221 F- CATGAATAGAATAAAAGTTGCAATA 
R- CCCCTTTAACGCTAATACGATCAA 
(Kariyama et al., 
2000) 
vanB E. faecalis ATCC 51299 F- GTGACAAACCGGAGGCGAGGA 
R- CCGCCATCCTCCTGCAAAAAA 
vanC1   F- GGTATCAAGGAAACCTC 
R- CTTCCGCCATCATAGCT 






E. faecalis ATCC 51299 F- CAGGAATTTATCGAAAATGGTAGAAAAG 
R- CACAATCGACTAAAGAGTACCAATC 
(Padmasini et al., 
2014) 
aph(3’)-IIIa  Streptomycin 
resistance 
E. faecalis ATCC 51299 F- GGCTAAAATGAGAATATCACCGG 
R- CTTTAAAAAATCATACAGCTCGCG 




Table 3: List of virulence genes primers 
Gene Description Control Strains Primer sequence (5’-3’) Reference  
gelE  Gelatinase production E. faecalis ATCC 29212 F- ACCCCGTATCATTGGTTT 
R- ACGCATTGCTTTTCCATC 
(Eaton & Gasson, 2001) 
cpd Sex pheromone  E. faecalis ATCC 51299 F- TGGTGGGTTATTTTTCAATTC 
R- TACGGCTCTGGCTTACTA 
cylB Cytolysin  E. faecalis ATCC 29212 F- ATTCCTACCTATGTTCTGTTA 
R- AATAAACTCTTCTTTTCCAAC 
cylA E. faecalis ATCC 29212 F-TGGATGATAGTGATAGGAAGT 
R- TCTACAGTAAATCTTTCGTCA 
efaAfs Cell wall adhesins E. faecalis ATCC 29212 F- GACAGACCCTCACGAATA 
R- AGTTCATCATGCTGTAGTA 






Repetitive extragenic palindromic-PCR (REP-PCR) was carried out using the (GTG)5 primer 
as described by Versalovic et al. (1994). DNA extraction was performed using the GeneJET 
Genomic DNA purification kit (ThermoFisher Scientific) according to the manufacturer’s 
guidelines. PCR was carried out in a total volume of 25 µl consisting of 12.5 µl of DreamTaq 
Green PCR Master mix (2X) (ThermoFisher Scientific), 1 µl of 5 µM (GTG)5 primer, 10.5 µl 
nuclease-free water and 1 µl of template DNA. The PCR cycling conditions were carried out 
as described by Tan et al. (2018). Amplicons were electrophoresed on a 1% agarose gel at 75 
V for 3 h in 1 X Tris-acetate-EDTA (TAE) buffer. A Quick-load® 1 kb DNA ladder (New 
England Biolabs) was used as the molecular weight marker. The gels were stained in 0.5 µg/ml 
ethidium bromide solution and visualised using the Gel Doc™ XR+ imaging system (Bio-Rad, 
South Africa). The resultant electrophoretic patterns were analysed using Bionumerics 
software version 6.6 (Applied Maths NV, Belgium) using Dice coefficient and clustering 
analysis through unweighted pair group with arithmetic averages (UPGMA) using 1% 
tolerance and 0.5% optimisation.  
 
3. Results 
3.1 Prevalence of Enterococcus spp. along the farm to food-production chain continuum 
A total of 134 enterococcal isolates were recovered along the farm to food-production chain 
continuum with 69% confirmed to the species level, and 31% confirmed to the genus level by 
PCR (Figure 1). Molecular screening confirmed 36% of the isolates as E. faecalis (n=48), 31% 
as E. faecium (n=42), 2% as E. gallinarum (n=2) and 31% as other Enterococcus spp. (n=42). 
No E. casseliflavus isolates were identified. E. faecalis dominated the isolates found in Week 
1 and 3, human samples, retail meat and abattoir samples while E. faecium was dominant at 
Week 4, in caecal and transport crate samples. Other Enterococcus spp. dominated at Week 5 
and within the house after the flock was removed. No Enterococcus isolates were recovered 
from “truck” at the transport sampling point nor “thigh” at the retail product level. 
 
3.2 Antibiotic susceptibility tests 
Zone diameters were interpreted and reported as intermediate or resistant using the CLSI 
breakpoints or otherwise stated (CLSI, 2017). Disk diffusion revealed resistance to tetracycline 
(80%), erythromycin (71%), nitrofurantoin (17%), ampicillin (15%), streptomycin (15%), 
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chloramphenicol (11%), ciprofloxacin (5%), tigecycline (4%), gentamicin (4%), teicoplanin 
(3%) among Enterococcus spp., but no vancomycin resistance (0%) (Table 4).  E. faecalis 
showed the highest rate of resistance to the following antibiotics:  erythromycin (90%), 
tetracycline (88%), streptomycin (27%), chloramphenicol (23%), tigecycline (10%) and 
gentamicin (6%) as compared to the other species. E. faecium and Enterococcus spp. 
dominated the resistance profiles for nitrofurantoin (19% and 31%, respectively). The highest 
prevalence of intermediate susceptibility across all species investigated was observed for 
ciprofloxacin (62%). The susceptibility profile of quinupristin-dalfopristin was only reported 
for E. faecium since it is only clinically relevant for this enterococcal species, where 24% of 
isolates were resistant, and 21% were of intermediate susceptibility. All E. faecium isolates 
were completely susceptible to vancomycin and gentamicin. However, 21% of E. faecalis 
showed intermediate susceptibility to vancomycin. Figure 2 depicts the resistant profiles of 
the Enterococcus isolates along the farm to food-production chain continuum. The occurrence 
of isolates resistant to tetracycline was observed throughout all the sample points of the 
continuum. The highest rates of resistance were noted for tetracycline and erythromycin 
(>75%) for isolates originating from faeces and litter (Week 1-5), human, abattoir, and retail 
meat. Figure 3 illustrates the prevalence of Enterococcus isolates showing intermediate 
susceptibility along the farm to food-production chain continuum. It can be noted that the 
occurrence of intermediate susceptibility to ciprofloxacin spans across all sample points at 
prevalences of 100%, 71%, 71%, 67%, 67% and 29% for the house, transport crates, retail 
meat, caecal samples, human samples and abattoir samples respectively.  Collectively, 37% of 
all enterococci were multidrug-resistant (MDR) (resistant to one or more antibiotics in three or 
more antibiotic classes). Separated by species, 43% percent of all E. faecium (n=18), 37% of 
all E. faecalis (n=17) and 33% of all Enterococcus spp. (n=14) were MDR. A total of 25 
antibiograms were observed (Table 5). E. faecalis and E. faecium showed 11 antibiograms, 
each. The other Enterococcus spp. showed seven antibiograms while E. gallinarum did not 
display any MDR phenotype. 
 
3.3 Detection of antibiotic resistance genes 
The prevalence of antibiotic resistance genes in the enterococcal isolates was as follows: tetM 
(76%), ermB (67%), aph(3’)-IIIa (12%) and vanC1 (1%) (Table 6). Most isolates that were 
resistant or showed intermediate susceptibility to erythromycin harboured the ermB gene. A 
total of 81% and 52% of E. faecalis and E. faecium contained the ermB gene, respectively. This 
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gene was present in 69% of Enterococcus spp. Phenotypic tetracycline resistance appeared to 
be closely related with the presence of tetM.  No tetK gene was detected in isolates showing 
phenotypic tetracycline resistance. The tetM gene was more prominent in E. faecium (86%), 
closely followed by E. faecalis (79%) and Enterococcus spp. (62%). All E. gallinarum isolates 
tested positive for the presence of a vancomycin resistance gene in accordance with the 
phenotypic profile. However, this was expected since the species is known for its inherent 
resistance via the vanC1 gene. None of the van genes tested was observed in E. faecalis or 
Enterococcus spp. although selected isolates showed intermediate susceptibility to 
vancomycin. The aph(3’)-IIIa gene was more commonly detected in E. faecalis (23%) as 
compared to E. faecium (7%) and Enterococcus spp. (5%) which corresponds to the high-level 
streptomycin resistance detected in the corresponding isolates. The aac(6’)-Ie-aph(2’’)-Ia 
gene, known for conferring gentamicin resistance, was not detected in any of the 134 
enterococcal isolates. 
 
3.4 Detection of virulence genes 
The overall prevalence of virulence factors detected among the isolates were as follows: 
efaAFm (54%), efaAFs (37%), cpd (37%), gelE (33%), cylA (3%) and cylB (3%) (Table 7).  E. 
faecalis showed the highest frequency of virulence genes compared to any other species with 
the following distributions: 100% efaAFs (n=48), 96% cpd (n=46), 81% gelE (n=39), 6% cylA 
(n=3) and 6% cylB (n=3). E. faecium showed 100% frequency for the presence of efaAFm 
(n=42) while no cylA or cylB was detected. The most prevalent virulence factor for 
Enterococcus spp. was the cell wall adhesion gene efaAFm at 71% (n=30). No virulence factors 
were detected for E. gallinarum. 
 
3.5 Repetitive Element Palindromic PCR (REP-PCR) 
The DNA fingerprints in the dendrograms generated by REP-PCR helped distinguish 
evolutionary relationships between all E. faecalis (n=48) and E. faecium (n=42) isolates along 
the farm to food-production chain continuum (Figure 4 and Figure 5 respectively). Isolates 
were grouped based on a similarity of ≥ 70%, in relation to selected phenotypic resistance and 
corresponding genetic determinants as tested in this study. Major REP-types were further 
defined for those isolates showing a similarity of ≥ 90%. E. faecalis was grouped into 20 REP-
types designated A-T. It was observed that 22% (11/48) of E. faecalis isolates were grouped 
into 4 major REP-types: F (n=2), J (n=2), L (n=4) and T (n=3). Of note, isolates from different 
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sampling points did not fall into the same major REP-types except for major cluster L 
consisting of isolates originating from Week 2 hand and Week 4 faeces samples. E. faecium 
was grouped into 17 REP-types designated A-Q. A total of 29% (n=12) E. faecium fell into 4 
major REP-types: F (n=2), G (n=2), J (n=2) and N (n=6). The largest clonal cluster showing a 
similarity index of >90% was N4 consisting of 4 isolates originating from caecal samples. 
Furthermore, this major clonal cluster had >70% similarity index relationship with Week 3 
isolates originating from litter samples (REP-type N and N1). REP-type F consisted of isolates 
from Week 4 litter and Week 5 faeces (F and F1, respectively) while REP-type K consisted of 
isolates originating from Week 5 litter and house (K and K1), respectively. This was contrary 




Given the importance of the poultry industry regarding the supply of meat protein globally, 
understanding the microbial quality of poultry using a farm to food-production chain approach 
could give a broad picture of the health risk that may be associated with this valuable protein 
source. In the current study, Enterococcus spp. were isolated at different sampling points within 
the farm to food-production chain continuum. A substantial percentage of these isolates were 
multidrug resistant (37%), and up to 54% of isolates carried one or more virulence factors that 
could potentially enhance their pathogenic potential in humans, under appropriate conditions.  
 
Although there was a fluctuation of species-dominance across the sampling continuum, this 
study revealed an overall predominance of E. faecalis strains (36%) followed by E. faecium 
(31%), and undifferentiated species of Enterococcus (31%). A very small proportion of E. 
gallinarum (2%) was detected. These findings are consistent with other poultry studies 
conducted in different countries that reported a higher incidence of E. faecalis in poultry meat 
and its associated environment (Furtula et al., 2013; Hidano et al., 2015; Hasan et al., 2018; 
Tyson et al., 2018). Although a limited number of studies within Africa have reported on the 
prevalence of Enterococcus spp. in poultry, most of the studies within the continent suggest 
that the incidence of Enterococcus in poultry is dominated by E. faecium strains (Bekele & 
Ashenafi, 2010; Ngbede et al., 2017). On the contrary, within South Africa where there is a 
particular paucity of related information, one study reported that E. faecalis was the most 
dominant species recovered from poultry cloacal samples which further corresponds to the 
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findings of the current study (Pillay et al., 2018). Such scarcity of information makes it difficult 
to draw sound conclusions, and this underscores the importance of including Enterococcus spp. 
in surveillance programs. Since E. faecalis is known to require extensive vitamins and amino 
acids for optimal growth (Lebreton et al., 2014), the absence of this species at Week 5 could 
be attributed to alterations of the feed/feed-additives. Furthermore, it is suggested that gut-
colonisation of chickens is age-dependent where E. faecalis dominates early colonisation but 
the introduction of AGPs, such as tylosin, allows E. faecium to thrive (Kaukas et al., 1987; 
Lebreton et al., 2014). Finally, at the mature stage of chicken growth, other species such as E. 
cecorum may displace both E. faecalis and E. faecium (Lebreton et al., 2014). These 
observations could explain the predominance of undifferentiated Enterococcus spp. (13%) 
followed by E. faecium (4%) noted at Week 5 in the current study.  
 
Due to potentially undesirable outcomes such as the antibiotic resistance associated with the 
use of antibiotics in food animals, the European Union has banned the use of most of these 
chemotherapeutic agents as growth promoters in the food-animal industry (Eagar et al., 2012). 
Regrettably, many of these antibiotics are still approved for use in South and are listed under 
the Stock Remedies Act No. 36 of 1947, indicating that the use of antimicrobials in South 
Africa is not as prudent (Eagar et al., 2012). Enterococcal isolates in this study displayed the 
highest prevalences of resistance (≥50%) to tetracycline (80%) and erythromycin (71%). High 
levels of tetracycline and erythromycin resistance may be attributed to extensive use of 
tetracycline and macrolide analogues for food animals which can create a selective 
environment for subsequent resistance (Eagar et al., 2012). The highest prevalence of 
intermediate susceptibility, across all species investigated, was observed for ciprofloxacin 
(62%). Ciprofloxacin resistance can be related to the application of analogues such as 
enrofloxacin administered for treatment of poultry (Eagar et al., 2012). Compared to E. 
faecalis, E. faecium is intrinsically more drug-resistant and therefore more difficult to treat 
(Higuita & Huycke, 2014). The findings of the present study revealed that all E. faecium 
isolates were susceptible to the clinically relevant antibiotics, vancomycin and gentamicin. 
However, it is concerning that the highest frequency of MDR phenotypes occurred for E. 
faecium (43%), displaying diverse antibiograms. These observations highlight the need to 
include a broader range of antibiotics, other than vancomycin, for surveillance programs. 
Consumption of poorly cooked or raw poultry contaminated with such MDR bacteria could 




Additionally, 24% of E. faecium isolates were resistant, and 21% were of intermediate 
susceptibility to quinupristin-dalfopristin which is concerning considering that this is among 
the last resort antibiotics for the treatment of vancomycin-resistant E. faecium (Rossolini et al., 
2014). While resistance to quinupristin-dalfopristin in poultry settings is assumed to be linked 
to agricultural use of virginiamycin, it is possible that cross-resistance may occur due to genetic 
linkage to genes conferring resistance to other drug classes such as macrolides (Bortolaia et al., 
2016). It is known that ermB can induce cross-resistance to streptogramin B (Isnard et al., 
2013), which could explain the intermediate susceptibility noted for quinupristin-dalfopristin. 
E. faecalis showed 21% intermediate susceptibility to vancomycin. Glycopeptides and their 
analogues are generally not included for veterinary use in South Africa (Eagar et al., 2012), 
suggesting that low-level cross-resistance resulting from other drug classes may be possible. 
There appeared to be some variations between resistance profiles and the presence of 
corresponding resistance genes. Majority of the E. faecalis (81%) isolates harboured the ermB 
gene while only 52% of E. faecium tested positive. This suggests that other mechanisms of 
macrolide resistance such as the presence of the ermA or msrC genes could have been involved 
as previously reported (Seputiene et al., 2012; Thumu & Halami, 2014). Most isolates that 
showed resistance to tetracycline were positive for the tetM gene. This corresponds with other 
findings, where among other tetracycline resistance genes such as tetL or tetO, the tetM gene 
was more frequently recovered from poultry sources (Kim et al., 2018; Hidano et al., 2015). 
The tetM gene is often harboured in the bacterial chromosome, residing within conjugative 
transposons of the Tn916 or Tn1545 family, with tetM in Tn1545 often associated with ermB 
which has implication for cross-resistance (Cauwerts et al., 2007). The aph(3’)-IIIa gene, 
although detected at a low level, was present in the majority of isolates showing resistance. 
Molecular detection did not confirm the presence of any of the tested van resistance genes 
(vanA, vanB, vanC1 and vanC2/3) in E. faecalis while vanC1 was confirmed in E. gallinarum 
isolates, as would be expected from these intrinsically resistant species (Hollenbeck & Rice, 
2012). However, it should be noted that nine gene clusters that confer glycopeptide resistance 
have been identified in enterococci: vanA, vanB, vanC, vanD, vanE, vanG, vanL, vanM and 
vanN (Raza et al., 2018). Given that not all the genes were tested in the current study, the tested 
isolates could still carry some of the resistance genes. Therefore, further studies involving a 
more comprehensive panel of genes or whole genome sequencing should be carried out to 





Several virulence factors have been attributed to the pathogenic potentials of Enterococcus spp. 
The findings of this study show that all E. faecalis and E. faecium were positive for their 
respective cell wall adhesin genes, efaAFs and efaAFm. There was also a high prevalence of 
gelatinase (gelE) and sex pheromone (cpd) genes, and to a lower extent, cytolysin (cylA and 
cylB) genes detected in E. faecalis. Similar results have been reported in poultry-based studies.  
Choi & Woo (2013) reported 100% prevalence of gelE and efaA in all high-level gentamicin-
resistant E. faecalis from poultry in Korea. More recently, Kim et al. (2018) reported the 
prevalence of gelE (95.3%) and efaA (80.5%) genes in antibiotic-resistant E. faecalis from 
poultry samples in Korea as did Pillay et al. (2018) reporting a high prevalence (>80%) of gelE 
in enterococci from poultry samples as compared to livestock or companion animals in South 
Africa. MDR enterococci possessing both virulence factors and an array of antibiotic resistance 
genes have the potential to be more effective as opportunistic pathogens (Chajęcka-
Wierzchowska et al., 2017). Furthermore, it is vital to understand the association between 
virulence and antibiotic resistance genes with mobile genetic elements in order to predict the 
risk of dissemination. It has been shown that enterococcal isolates of poultry origin were able 
to transfer both antibiotic resistance and virulence genes to recipient strains (Kim et al., 2018). 
This highlights the risk of Enterococcus from poultry serving as a reservoir for resistance and 
virulence genes. 
 
Determination of clonality was carried out using REP-PCR which revealed that the isolates 
along the farm to food-production chain continuum were very diverse with 20 REP-types (A-
T) designated for E. faecalis and 17 REP-types (A-Q) for E. faecium. Regarding E. faecalis, 
during Week 1-2, the clones did not appear to establish themselves into major clusters across 
the continuum, except for a single isolate from Week 2 human hand and Week 4 faecal sample. 
However, during Week 3 and 4, isolates originating from faeces samples formed a definitive 
REP-type cluster (T-T5) with similar phenotypic profiles. It is interesting to note that REP-
type O consisted of isolates from Week 2 human isolates that were >70% genetically related 
to those originating from the abattoir. Similar findings have been reported by Tan et al. (2018) 
where enterococcal clones of human (farmer) and swine origins showed high similarity by 
pulse-field gel electrophoresis. This may suggest that human handling of poultry at the 
slaughterhouse may contribute to enterococcal contamination. More isolates fell within the 
major REP-types (29%) for E. faecium with the largest clonal cluster belonging to major REP-
type N originating from caecal samples. Furthermore, this major clonal cluster had >70% 
similarity index relationship with Week 3 isolates originating from litter samples (REP-type N 
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and N1), indicating possible circulation of these isolates within the flock and along the different 





5.  Conclusion 
To the best of our knowledge, this is the first study in South Africa that investigated the 
molecular epidemiology of antibiotic-resistant Enterococcus spp. using the farm to food-
production chain approach. This study highlights the high prevalence of MDR Enterococcus 
isolates harbouring both resistance and virulence genes in diverse permutations and 
combinations which can serve as a reservoir for the potential transfer of these genes from 
poultry to humans through the farm to food-production chain continuum. The findings also 
underscore the need to include Enterococcus spp. in food animal antibiotic resistance 
surveillance programs. Such information is critical to inform decision making regarding the 
food safety of poultry, specifically the design and implementation of appropriate measures that 
could aid in the prevention of potential health risks associated with its consumption, especially 
in developing countries. 
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Table 4: Susceptibility profile of all isolates recovered from the farm to food-production chain continuum 
 Susceptibility profile  
 E. faecalis 
(n=48) 
 E. faecium 
(n=42) 
 Enterococcus spp. 
(n=42) 
 E. gallinarum 
(n=2) 
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Table 5: Multidrug-resistant profiles of Enterococcus isolates. 






ERY-CHL-QD 0 1 0 
NIT-TET-ERY 0 0 4 
NIT-TET-ERY-AMP 0 1 2 
NIT-TET-ERY-CIP 0 2 0 
NIT-TET-ERY-QD 0 2 0 
NIT-TGC-TET-ER 0 1 0 
TEC-NIT-ERY-CHL-GEN-STR 1 0 0 
TEC-NIT-ERY-CHL-STR 1 0 0 
TEC-NIT-TET-ERY 0 0 1 
TEC-TET-ERY-GEN-STR 0 0 1 
TET-ERY-AMP 2 2 4 
TET-ERY-AMP-CHL-GEN-STR 2 0 0 
TET-ERY-AMP-QD 0 1 0 
TET-ERY-AMP-STR 1 0 0 
TET-ERY-CHL 1 0 0 
TET-ERY-CHL-STR 5 0 0 
TET-ERY-CHL-STR-QD 0 1 0 
TET-ERY-CIP 0 2 0 
TET-ERY-CIP-AMP-CHL-GEN-STR 0 0 1 
TET-ERY-QD 0 2 0 
TET-ERY-STR 0 3 1 
TGC-TET-ERY 1 0 0 
TGC-TET-ERY-AMP 1 0 0 
TGC-TET-ERY-AMP-STR 1 0 0 
TGC-TET-ERY-CHL-STR 1 0 0 
Total (n=49; 37%) 17 (35%) 18 (43%) 14 (33%) 
Abbreviations: AMP; ampicillin, ERY; erythromycin, CHL; chloramphenicol, CIP; ciprofloxacin, GEN; gentamicin, NIT; nitrofurantoin, Q-D; 
quinupristin-dalfopristin, STR; streptomycin, TEC: teicoplanin, TET; tetracycline, TGC; tigecycline. 
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Table 6: Prevalence of ABR genes in Enterococcus spp. 
Antibiotic resistance gene E. faecalis (n= 48)  E. faecium (n= 42) E. gallinarum (n= 2) Enterococcus spp. (n= 42) Total (n= 134) 
tetM 38 (79%) 36 (86%) 2 (100%) 26 (62%) 76% 
ermB 39 (81%) 22 (52%) 0 (0%) 29 (69%) 67% 
aph(3’)-IIIa  11 (23%) 3 (7%) 0 (0%) 2 (5%) 12% 
vanC1 0 (0%) 0 (0%) 2 (100%) 0 (0%) 1% 
tetK 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0% 
vanA 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0% 
van B 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0% 
vanC2/3 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0% 
aac(6’)-Ie-aph(2’’)-Ia  0 (0%) 0 (0%) 0 (0%) 0 (0%) 0% 
 
Table 7:  Prevalence of virulence factors among Enterococcus spp. 
Virulence genes E. faecalis (n=48)  E. faecium (n=42) E. gallinarum (n=2) Enterococcus spp. (n=42) Total No. (n=134) 
efaAFm 0 (0%) 42 (100%) 0 (0%) 30 (71%) 72 (54%) 
efaAFs 48 (100%) 1 (2%) 0 (0%) 1 (2%) 50 (37%) 
cpd 46 (96%) 1 (2%) 0 (0%) 2 (5%) 49 (37%) 
gelE 39 (81%) 2 (5%) 0 (0%) 3 (7%) 44 (33%) 
cylA 3 (6%) 0 (0%) 0 (0%) 1 (2%) 4 (3%) 
cylB 3 (6%) 0 (0%) 0 (0%) 0 (0%) 3 (3%) 
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Sampling sites along the farm to food-production chain continuum
E. faecalis E. faecium




Figure 2: Prevalence of all Enterococcus spp. showing resistant profiles along the farm to food-production chain continuum. *Q-D is reported for 
E. faecium isolates only. 
Abbreviations: TEC: teicoplanin; NIT: nitrofurantoin; TGC: tigecycline; TET: tetracycline; ERY: erythromycin; VAN: vancomycin; CIP: 












































































































































Litter/faeces (n=82) Transport crates (n=7) Abbatoir (n=7) Caecal (n=9) Retail Meat (n= 17) House rinse (n=9) Human (n=3)
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Figure 3: Prevalence of all Enterococcus spp. showing intermediate susceptibility along the farm to food-production chain continuum. *Q-D is 
reported for E. faecium isolates only. 
Abbreviations: TEC: teicoplanin; NIT: nitrofurantoin; TGC: tigecycline; TET: tetracycline; ERY: erythromycin; VAN: vancomycin; CIP: 







































































































































Litter/faeces (n=82) Transport crates (n=7) Abbatoir (n=7) Caecal (n=9) Retail Meat (n= 17) House rinse (n=9) Human (n=3)
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Figure 4: Dendrogram showing REP-type groups of E. faecalis isolates, based on the similarity 
index, recovered along the farm to food-production chain continuum. E. faecalis ATCC 29212 
was used as the quality control strain. The solid red line indicates the REP-type cut off while 
the dashed red line indicates the major REP-type cut off. Abbreviations: ERY: erythromycin; 
TET: tetracycline; VAN: vancomycin: STR: streptomycin. * indicates intermediate 
susceptibility.



















































































































































































































































































Figure 5: Dendrogram showing REP-type groups of E. faecium isolates, based on the similarity 
index, recovered along the farm to food-production chain continuum. E. faecium ATCC 35667 
was used as the quality control strain. The solid red line indicates the REP-type cut off while the 


















































































































































































































































dashed red line indicates the major REP-type cut off. Abbreviations: ERY: erythromycin; TET: 
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This study describes the antibiotic resistance profiles, antibiotic resistance and virulence genes and 
assesses the genetic relatedness of 134 Enterococcus isolates from an intensive poultry-production 
farm in the uMgungunglovu in Kwazulu-Natal, South Africa. 
 
3.1 Conclusions 
The following conclusions were drawn in reference to the objectives of the study: 
• Enterococcus isolates were successfully isolated and cultured, from the following farm to 
food-production chain sampling sites: Week 1-5 litter and faeces, human (hands), transport 
crates, abattoir, retail meat (neck and whole carcass), caecal and final house rinsate. 
• One-hundred and thirty-four isolates were successfully identified using API and PCR. 
• The antibiotic susceptibility profile obtained using Kirby-Bauer disk diffusion revealed the 
following resistance profiles for Enterococcus isolates: tetracycline (80%), erythromycin 
(71%), nitrofurantoin (17%), ampicillin (15%), streptomycin (15%), chloramphenicol 
(11%), ciprofloxacin (5%), tigecycline (4%), gentamicin (4%), teicoplanin (3%) but no 
vancomycin resistance (0%). E. faecalis showed resistance to the following antibiotics:  
erythromycin (90%), tetracycline (88%), streptomycin (27%), chloramphenicol (23%), 
tigecycline (10%) and gentamicin (6%) as compared to the other species. E. faecium and 
Enterococcus spp. dominated the resistance profiles for nitrofurantoin (19% and 31%, 
respectively). 
• The highest rate of intermediate susceptibility across all species investigated was observed 
for ciprofloxacin (62%). E. faecium showed 24% resistance to quinupristin-dalfopristin 
while 21% were intermediate. All E. faecium isolates were completely susceptible to 
vancomycin and gentamicin. However, 21% of E. faecalis showed intermediate 
susceptibility to vancomycin. 
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• Forty-three percent of E. faecium (n= 18) were multidrug-resistant (MDR) while 37% 
percent of E. faecalis (n= 17) and 33% of Enterococcus spp. (n= 14) were MDR. A total 
of 25 MDR antibiograms were observed. 
• The overall prevalence of antibiotic resistance genes were as follows: tetM (76%), ermB 
(67%), aph(3’)-IIIa (12%) and vanC1 (1%). The tetK, vanA, vanB, vanC2/3 and aac(6’)-
Ie-aph(2’’)-Ia genes were not detected 
• The overall prevalence of virulence factors detected among the isolates were as follows: 
efaAFm (54%), efaAFs (37%), cpd (37%), gelE (33%), cylA (3%) and cylB (3%). 
• Dendrograms generated by REP-PCR helped distinguish evolutionary relationships 
between all E. faecalis and E. faecium.  
• E. faecalis was grouped into 20 REP-types, with ≥70% relatedness, designated A-T and 
22% of E. faecalis isolates were grouped into 4 major REP-types displaying ≥ 90% 
relatedness: F (n= 2), J (n= 2), L (n= 4) and T (n= 3). 
• E. faecium was grouped into 17 REP-types, with ≥70% relatedness, designated A-Q and 
29% of E. faecium fell into 4 major REP-types with ≥ 90% relatedness: F (n= 2), G (n= 2), 
J (n=2) and N (n= 6). The largest major REP-type cluster originated from caecal samples. 
Furthermore, this major clonal cluster had >70% similarity index relationship with Week 
3 isolates originating from litter samples indicating possible circulation of these isolates 
within the flock and along the different stages of the production process. 
 
3.2 Limitations 
• The study was limited to one poultry-production farm, which is not a true representation 
of the prevalence of ABR Enterococcus spp. throughout KwaZulu-Natal or South Africa. 
• All isolates showing intermediate susceptibility should be interpreted with caution as it 
cannot be concluded if such isolates were susceptible or resistant as the intermediate 
susceptibility profile does not necessarily imply the presence of a resistance mechanism. 
Thus, they should be considered potentially resistant. 
• Statistical analysis should be explored to draw conclusive correlations between phenotypic 




3.3 Future recommendations 
That the following recommendations are made based on the findings of this study: 
• Molecular mechanisms such as the genes encoding quinupristin-dalfopristin resistance 
(vatD and vatE) in E. faecium need to be investigated. 
• Molecular detection of the Tn916 or Tn1545 transposons should be investigated as tetM is 
often associated with ermB in transposon Tn1545. 
• Additional mechanisms of tetracycline resistance should be investigated such as efflux 
pumps encoded by tetL or other ribosomal protection proteins such as tetO, tetT, tetS and 
tetW. 
• Macrolide efflux pump systems encoded by mef and msrC should be investigated for 
erythromycin resistance. 
• Other genes known to confer resistance to vancomycin (vanD, vanE, vanG, vanL, vanM 
and vanN) should be considered for isolates showing intermediate susceptibility in addition 
to carrying out MICs. 
• Additional virulence genes should be studied to gain further insight into the virulence 
potential of isolates, e.g. biofilm-association pili (epb), aggregation substance (asa), 
adhesins (ace) and collagen adhesins (acm).  
• Other clonal typing methods such as PFGE or multilocus sequence typing (MLST) should 
be used to gain clearer insight into clonal complexes. 
• Whole-genome sequencing should be considered for a more accurate representation of 
isolates’ genomic profile.  
• Further studies including more poultry-production systems should be investigated to 
provide a better representation of ABR in Enterococcus spp. along the farm to food-






































A; E. faecalis ATCC 29212 sodA (360 bp) and tuf (112 bp), B; E. faecium ATCC 35667 sodA (215 bp) and tuf (112 bp), C; E. 
gallinarum clinical strain sodA (173 bp) and tuf (112 bp); D; E. casseliflavus ATCC 70327 sodA (288 bp) and tuf (112 bp). All PCR 
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A; vanA amplified from E. faecium ATCC 700221, B; vanB from E. faecalis ATCC 51299, C; vanC2/3 from E. casseliflavus ATCC 
70327, D; ermB from E. faecalis ATCC 51299, E; tetK (718 bp) and tetM (657 bp) from S. aureus clinical strain and E. faecalis 
 A B C D 























ATCC 29212, respectively, F; aph(3’)-IIIa from E. faecalis  ATCC 51299, G; aac(6’)-Ie-aph(2’’)-Ia  from E. faecalis ATCC 51299. 
All PCR products were run alongside a 100 bp DNA molecular weight marker (NEB Quick-Load®, Massachusetts, USA). 















Lanes 1 and 8; 100 bp DNA molecular weight marker (NEB Quick-Load®, Massachusetts, USA), Lane 2; cylA (E. faecalis ATCC 
29212), Lane 3; cylB (E. faecalis ATCC 29212), Lane 4; cpd (E. faecalis ATCC 51299), Lane 5; gelE ((E. faecalis ATCC 29212), 




400 bp 517 bp 








Appendix 7: Table of raw data 




ID Isolate PCR 
speciation 









T12b 2 E. faecalis I S S S R S S S S S S 
 
TEC ER ermB gelE-cpd-
efaAFs 
T2 3 E. faecalis S S S S R I S S S S S 
 
ER VAN ermB gelE-cpd-
efaAFs 
T2b 4 E. 
gallinarum 
S S S R S I I S S S S 
 
TE VAN CIP tetM-
vanC1 
- 
Ta 5 E. 
gallinarum 
S S S R S I I S S S S 
 
TE VAN CIP tetM-
vanC2 
- 
VRE+W2F3 6 Enterococcus 
spp 





VRE+W2F5 7 Enterococcus 
spp 











H10 9 E. faecalis S S S R R I I S R S S 
 






H11 10 E. faecalis S S S R R S I S I S S 
 






W2F12 11 Enterococcus 
spp 
S S S S R S S S S S S 
 
ER ermB efaAFm 
W2F4 12 Enterococcus 
spp 





W2F5 13 E. faecium S S S R R S I S I S S R TE ER CIP 
CHL QD 
tetM efaAFm 
W2F2* 14 E. faecalis S S S R R I I S I S S 
 






W2F3* 15 E. faecalis S S S R R S S S I S S 
 
TE ER CHL ermB gelE-cpd-
efaAFs 
W2F5* 16 E. faecalis S I S R R S I S S S S 
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ID Isolate PCR 
speciation 





W2L4 18 Enterococcus 
spp 





W2L1* 19 E. faecium S S S S R S I S S S S S ER CIP ermB efaAFm 
W2L3* 20 E. faecium S I S R R S I S I S R I NIT TE ER 














W2L6* 22 E. faecalis S S R S R I S S I S S 
 
ER VAN CHL ermB gelE-cpd-
efaAFs 





W3L3 24 Enterococcus 
spp 
S I S R R S I S I S S 
 




















W3L6 28 Enterococcus 
spp 
S S S R R S S S I S S 
 









W3L8 30 E. faecium S S S R R S I R I S S I TE ER CIP 




W3L12 31 Enterococcus 
spp 
S R S S I S S S S S S 
 
NIT ER ermB efaAFm 
W3F11 32 Enterococcus 
spp 
S R S S R S S S S S S 
 
NIT ER - - 
W3F1 33 Enterococcus 
spp 
S I S R R S S S S S S 
 
NIT TE ER tetM-
ermB 
efaAFm 
W3F3 34 Enterococcus 
spp 
S S S R R S I S S S S 
 
TE ER CIP tetM-
ermB 
efaAFm 
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ID Isolate PCR 
speciation 





W3F7* 35 E. faecalis R R S I R S I S R S R 
 
TEC   NIT TE 








W3F10* 36 E. faecalis R R S S R S I S R R R 
 
TEC NIT ER 







W3F3* 37 E. faecalis S S R R R I I S R S R 
 
NIT TGC TE 








W3F4* 38 E. faecalis S S S R R S I S R S R 
 








W3F8* 39 E. faecalis S S S R R I I S R S R 
 
TE ER VAN 







W3F9* 40 E. faecalis S S S R R S I S R S R 
 
TE ER CIP 






W3F6* 41 E. faecalis S S S R R S I S R S R 
 












W4F15 43 E. faecalis S S S R R S I S I S S 
 











W4F23 45 E. faecium S S S R R S S S S S S S TE ER tetM efaAFm 
W4F31 46 E. faecium S S S R I S S S S S S S TE ER tetM efaAFm 
W4F37 47 E. faecium S R R R I S I S S S S S NIT TGC TE 
ER CIP 
tetM efaAFm 
W4F39 48 E. faecium I R S R I S I S S S S S TEC   NIT TE  
ER CIP 
tetM efaAFm 
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speciation 





W4F1* 49 E. faecalis S S S R R S I S I S S 
 






W4F2* 50 E. faecalis S S S R R S I S I S S 
 






W4F3* 51 E. faecalis S S S R R S I S I S S 
 






W4F4* 52 E. faecalis S S S R R S I S I S S 
 






W4L10 53 E. faecalis S S S R R S I S S S R 
 






W4L11 54 Enterococcus 
spp 
S S S R R S I S S S S 
 
TE ER CIP tetM-
ermB 
efaAFm 
W4L13 55 E. faecium S S S R R S I S S S S S TE ER CIP tetM efaAFm 
W4L14 56 Enterococcus 
spp 
S I S R R S I R S S S 
 
NIT TE ER 
CIP AMP 
tetM efaAFm 
W4L20 57 E. faecium S S S S R S I S S S S R ER CIP QD - efaAFm 
W4L21 58 E. faecium S S S R I S S S I S S S TE ER CIP tetM efaAFm 
W4L22 59 E. faecium S S S R I S I R S S S S TE ER CIP 
AMP 
tetM efaAFm 
W4L24 60 Enterococcus 
spp 





W4L26 61 E. faecium S S S R I S I S S S S S TE ER CIP tetM efaAFm 










W5F2 64 Enterococcus 
spp 
S R S R R S I R S S S 
 





W5F3 65 Enterococcus 
spp 
S I S S I S I S S S S 
 
NIT ER CIP ermB efaAFm 
W5F4 66 Enterococcus 
spp 
S S S S I S I S S S S 
 
ER CIP ermB efaAFm 
W5F5 67 E. faecium S S S R R S I S R S R R TE ER CIP 
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W5F8 69 Enterococcus 
spp 
S I S R R S R R R R R 
 
NIT TE ER 





W5F10 70 Enterococcus 
spp 
S R S R R S S S S S S 
 
NIT TE ER ermB efaAFm 
W5F14 71 Enterococcus 
spp 
S R S R R S S S S S S 
 
NIT TE ER tetM-
ermB 
efaAFm 
W5F16 72 Enterococcus 
spp 
S I S R R S I R S S S 
 







R R S R R S S S S S S 
 
TEC NIT TE 
ER  
- - 
W5L2 74 Enterococcus 
spp 
S S S R R S S S S S R 
 





W5L4 75 Enterococcus 
spp 
S S S S R S S S S S S 
 
ER ermB efaAFm 
W5L5 76 Enterococcus 
spp 
S S S S R S S S S S S 
 
ER - gelE 
W5L6 77 E. faecium S S S S R S I S I S S S ER CIP CHL ermB efaAFm 
W5L7 78 Enterococcus 
spp 
S R S R R S S R I S S 
 





W5L8 79 Enterococcus 
spp 
S S S R R S S R S S S 
 
TE ER AMP tetM-
ermB 
- 
W5L9 80 Enterococcus 
spp 
S S S R S S I S S S S 
 
TE CIP tetM - 
W5L10 81 E. faecium S S S R I S I S S S S S TE ER CIP tetM-
ermB 
efaAFm 
VRE+W5L1 82 Enterococcus 
spp 
S R S S I S S S S S S 
 
NIT ER - - 
VRE+W5L2 83 Enterococcus 
spp 
S R S R R S S S S S S 
 
NIT TE ER tetM-
ermB 
efaAFm 





VRE+W5L5 85 Enterococcus 
spp 
S R S R R S I S I S S 
 










ID Isolate PCR 
speciation 





Crate 9 87 E. faecium S I S S I S I S I S S I NIT ER CIP 
QD 
tetM efaAFm 
Crate 10 88 Enterococcus 
spp 
S S S R R S I R S S S 
 
TE ER CIP 
AMP 
ermB efaAFm 
Crate 12 89 E. faecium S I S S R S I S R S S R ER CIP CHL 
QD 
ermB efaAFm 
Crate 1 90 Enterococcus 
spp 





Crate 2 91 E. faecium S I S R S S S S S S S S NIT TE tetM efaAFm 
Crate 3 92 E. faecium S S S R I S I S I S S R TE ER CIP 
CHL QD 
tetM efaAFm 
Abattoir 16 93 E. faecalis S S S R R S S S S S S 
 
TE ER tetM gelE-
efaAFs 
Abattoir 17 94 E. faecalis S S S R R S S S I S S 
 




Abattoir 20 95 E. faecalis S S S R R S S S I S S 
 
TE ER CHL tetM gelE-cpd-
efaAFs 
Abattoir 22 96 E. faecalis S S S R R S I S I S S 
 






Abattoir 23 97 E. faecalis S S S R R S S S I S S 
 
 TE ER CHL tetM gelE-cpd-
efaAFs 
Abattoir 3* 98 E. faecalis S S S R I S S S S S S 
 
TE ER tetM gelE-cpd-
efaAFs 
ABA 3 99 E. faecalis S S S R R S I S I S S 
 




Neck 9 100 E. faecalis S S S R R S I S I S S 
 












Neck 11 102 E. faecalis S S S R R I I S R S R 
 
TE ER VAN 







Neck 12 103 E. faecalis S S S R I S I S S S S 
 
TE ER CIP tetM gelE-cpd-
cylA-cylB-
efaAFs 
Neck 1  104 Enterococcus 
spp 
R S S R R S I S S R R 
 
TEC   TE ER 









ID Isolate PCR 
speciation 





Neck 3 105 E. faecalis S S S R I S I S S S S 
 
TE ER CIP tetM cpd-cylA-
cylB-
efaAFs 
Neck 4 106 E. faecalis S S S R I I S S S S S 
 
TE ER VAN tetM gelE-cpd-
efaAFs 
Neck 5 107 E. faecalis S S S R R I S S I S S 
 






Neck 1* 108 E. faecalis S S S R S S I S S S S 
 
TE CIP tetM gelE-cpd-
cylA-cylB-
efaAFs 
Neck 6 109 E. faecalis S S S R R S I S S S S 
 




Carcass 6* 110 E. faecalis S S R R R S I R I S R 
 
TGC TE ER 







Carcass 10 111 E. faecalis S S S R R S I R S S S 
 




carcass 14 112 E. faecalis S S S R R S I R I S S 
 




Carcass 9* 113 E. faecalis S S S R R S S R S S R 
 






Carcass 1 114 E. faecalis S S R R R S I R I S S 
 
TGC TE ER 
CIP AMP CHL 
ermB gelE-cpd-
efaAFs 
Carcass 8 115 E. faecalis S S S R R S S R R R R 
 









Carcass 5* 116 E. faecalis S I S R R S I R R R R 
 
NIT TE ER 
CIP AMP CHL 
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Caecal 10 118 E. faecium S S S R I S I S S S S I TE ER CIP QD tetM gelE-
efaAFm 
Caecal 11 119 E. faecium S S S S I S I S S S S S ER CIP - efaAFm 
Caecal 12 120 E. faecium S R S R I S I S S S S S NIT TE ER 
CIP 
tetM efaAFm 
Caecal 13 121 E. faecium S S S R I S I S S S S S TE ER CIP tetM efaAFm 
Caecal 14 122 E. faecium S S S R S S S S S S S S TE tetM efaAFm 
Caecal 5 123 E. faecium S I S R I S I S S S S S NIT TE ER 
CIP 
tetM efaAFm 
Caecal 6 124 Enterococcus 
spp 
S S S R I S S S S S S 
 
TE ER tetM efaAFm 






House 4 126 Enterococcus 
spp 
S I S S I S I S S S S 
 
NIT ER CIP - efaAFm 





House 6 128 Enterococcus 
spp 
S I S S I S I R S S S 
 
NIT ER CIP 
AMP 
- efaAFm 
House 8 129 Enterococcus 
spp 
S I S S I S I S S S S 
 
NIT ER CIP - efaAFm 
House 9 130 Enterococcus 
spp 
S R S S I S I S S S S 
 
NIT ER CIP tetM-
ermB 
efaAFm 
House 3 131 Enterococcus 
spp 
S I S S I S I S S S S 
 
NIT ER CIP - efaAFm 
House 11 132 E. faecalis S S R R R I I S S S S 
 






House 12 133 Enterococcus 
spp 
S R S R I S I S S S S 
 
NIT TE ER 
CIP 
tetM efaAFm 
House 13 134 Enterococcus 
spp 
S R S R I S I S S S S 
 










































A: lane 1: 1 kb DNA molecular weight marker (NEB Quick-Load®, Massachusetts, USA), Lane 
2: E. faecalis ATCC 29212, Lane 3: E. faecium ATCC 35667, Lane 4: E. gallinarum clinical 



























B: lane 1: 1 kb DNA molecular weight marker (NEB Quick-Load®, Massachusetts, USA), Lane 
2 - 14: isolate ID 116-128, Lane 15: 1 kb DNA molecular weight marker. 
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